Gene list
Applied filters:
COG category: Cell wall/membrane biogenesis
Organism: Staphylococcus haemolyticus JCSC1435, JCSC1435
Gene type: CDS
Number of genes found: 123
Show UniProt / TrEMBL protein name | View in Fasta format (DNA) | View as list | ||||
# Staphylococcus haemolyticus JCSC1435, JCSC1435 >SH1736 MFHHISVMLNETIDYLDIKEDGIYVDCTLGGAGHALYLLNQLNDDGRLIA IDQDTTALDNAKEVLKDHLHKVTFVHSNFRELTDILKNLNIEKVDGIYYD LGVSSPQLDVPERGFSYHHDAKLDMRMDQTQQLSAYEVVNQWPYEALVKI FYRYGEEKFSKQIARRIETHREHQPIETTLELVDIIKEGIPAKARRKGGH PAKRVFQAIRIAVNDELSAFEDSIEQAIELVKVGGRISVITFHSLEDRLC KQMFQEYEKGPDVPRGLPIIPEAYTPKLKRVNRKPITATDTDLDENNRAR SAKLRVAEILK >SH1598 MIHSGKIRIDINPEKQNRHCKNHRLFEESKSKAIKNNYMLPSYTTIPNRE LNKLLMEKSNTGIMLLVNNKFNKKEIIDFGVVIGKAFVNGRYINTKLGKV HYSKTGTHVVPYIKKEMKK >SH1089 MGSSIVLKMLNVTHYYRSKKNRKWYLPFGYAAEDIELNNISLHIYQGEAL AIIGEPGASKTLLGRIIAGDIKPDRGKINKSVSTYYGDIKDKHLIHLTVR QYVKEIQRLFSYETTSHSVDQIIKFAHLDDKSTFNINMLSHSDFAQLILS IARVCRKELIILNHIIEHLDEDFLEKAKQLSKDYVNDNNSLVFIDNDLEK VEKVSNYVAWISHGQVRMEGSLNQVLPVFKEHEQDRMSIGNDEEQQNFDL DWKESRSRLPEMSYNFKRVERYRHAKVPDFVVRFWTILIASLICLAIVGA LVVNNIGRFDVPIIEAQKKVENKDPFEEKLAYGIVLDDSITLNGDSNTKV PKYAFLTITGENSKKYRVNIDNQDYVVEKHKLQYFNPAALYESHSFKKLS PYMKSNYSNFVDYYNSHLHKKHDRVKKTLVPNKDSRYVVGVTQQPVEMLF NDQDKLTGFVFPIINKDELKDKYHINQDLWIVKSGDGYLIADMKNSKWIY IEL >SH0476 MKEQYGVYSVQPIIVDDIEEELRQGKMIIKTAEEQNIDYVVYSTAGGVNR DRTGPHFEALADIENELKDSSLNYTIIKPSFFMDNFLRITKVENGEIMIP EFINQDVKFAMISSIDIARIASNVFGNPEKYNHQAIEIASDELTLKEVVK TFAMVTGKPTEIKGSFSSGTAERGWLEEKGYIIDFNQMDEINPGRLTLEQ WISEVNF >SH0542 MIREAKIEDLPAILSIYNDAILHTTAVYTYDIQTLDERKAWFDMKNKANE PIFVFEQAGKAVGFATYGQFRNWPAYLYSIEHSIYVDKSNRGKGIASQLL QHLIEDARTRNYRTIVAGIDASNDSSIKLHEKFNFKHAGTIQNVGYKFDR WLDLAFYQYDLHDK >SH0385 MKRIFDIGISSMILFFSLPVLVIIFILSFIFLGKPVFFKQERAGLNGEPF NIIKFRTMKDKRDSEGKLLPNKDRANWFGDILRSTSIDELPQLFNVLKGD LSLVGPRPLHIEYNQYYNDRQKKRLDVRPGITGLAQINGRNTISWTNKFQ YDTWYVENMSTILDAYIIYKTFSKVLKRQDINSKDNTQVERFNGNN >SH1731 MKDKRRKDNKVSSIQSLIEKRNRELNNEEHLSNHDANHKDKNKISTDDAQ LYKINKPNETSKQQDQNQSIDEDNFNNQSNESEQLEQNEAIEQSNETSDE NAQNVESTKTNDSHRLSTNSSENTYKLSIKDRVKEFNDNRKRKKHAKSTQ FDHLSPQERKEQLRIQRRKRQKRIQYVIITFLVLLIILFLLYMFTPLSRI SNIKISGNNNVSNSQVEKALDVKDNSRMYTYSKRKGIQNLKKNDLIKDVK IKKQLPNTLKVQITENQVVGVVKEKNKYVPIIEGNQELKNFDGNIAGSGP ILEGFKGEEKSNMIKSLSKMSPEIRDMISEIKYAPKQNSPNRILLYMQDD MQVVGNIKTIANKIKYYPQMSQSLSKDDSGNLKTQGYIDLSVGASFIPYN ENSSGDSKSDQNVRQKSQQETDAKDELQSALNKINEQSDSNN >SH0483 MKQFIKIVMTILICVGIGVSVTYLIREIDIQPSQMTLNDDNQFGDWKRDG RLTHGYGTYNHGLEFEGNDKHYGNDYDLPENTEVLAATDGVVTRLFEDEL GGKVIQISESNGQYHQWYMHLNDFKVTQGQKVKAGDVIALSGNTGEQTTG SHLHFQRMKGGIGNDYAEDPQPFINQLPEKEKSLFNI >SH2430 fibrinogen-binding protein SdrG MNKLAAASQGQNVNDLITVSNQYIEEGQNNDGIIRAHEDEPITYHSDITV DDAVNSGDTMTIDYDSHTIPSDLTDQYFVPDIADSNGDIIATGTYDDATK RATYTFTVFVDTHSNVTGTLSLSSFIDKSKVPARDTNIDMTFKTANTAYN QNFTVDYQYPEVEGDSNI >SH1061 MRQWTATHLAKLARKASIAAGKKGTDLPGQVARKVDQNILRKLAAQVDDI VFISGTNGKTTTSNLIGHTLKANHIDIIHNNEGANMAAGITSAFIMQSTK NTKVAIIEIDEGSIPRVLKEVTPSMMIFTNFFRDQMDRFGEIDIMVNNIA KSISNKGIKLLLNADDPFVSRLKIASDSIVYYGMKAHAHEFEQSTMNESK YCPNCGKLLVYDYIHYNQIGHYHCSCGFKRELPKYEVSSFTVSPFLALNI NETTFNMKIAGDFNAYNALAAYTVLRELGLNDESIRIGFESYTSDNGRMQ YFKLDYKEAMINLAKNPAGMNASLSVGEQLVGKKVYVISLNDNAADGRDT SWIYDADFEKLSEQNIETIIVTGTRAEELQLRLKLAEVNVPIILEKDIYK ATAMTMNYEGFTVAIPNYTSLSPMLEQLNRSFKGGQ >SH2190 MKIRVIVPCFNEGEVVTKTYDKLTEILMEDSLDKGYDYDLLFVDDGSKDN TIDHVQHLASLDQHVKYISFSRNFGKESAMIAGFQHSVKCDAVVMVDGDL QHPPEFIPQMIEGFQEGYDQVIAKRDRTGENIARKSMTKLYYKLINSFVE DIEFIDGVGDFRLLSQRAVKAMSSLKEYNRFSKGLFEWIGYNTKIFTYQN VEREAGHSKWTFTKLLNYGIDGLISFNNKPLRAMIYLGMTIFSLSIVYIL YLLIGIMVNGINNPGYFTTIAAVLLIGGIQLISIGVVGEYIGRIYYEVKQ RPKYIVQASNLKEPTHDLKVVEQEKEKVH >SH1090 MIDNILLYIKLFPSLIKFTKQRIIDTWKRFAILFIAELVLVLIALITLSF IEIEDISKARWLYRIVAMITFATMFATIFKSFKEYSQDYLITKSFQSTPL ITTVANALIGSSICCILSIITLLFKPVNFDASFTAFIVFYIMMILFIIFI SVTLGLLDIIYKNMTMIFWLAVVINFFIVPIIFIPSANENLMIQLLKLNP LFYLIDGLATSTIYGVVNMYNISYHIYFILIIVTIGAINFMLMRYVDKVR IIV >SH0186 MKKFLTILILSTLILCACNFEQDVENKHDRNASTKTTGNEQKKKEVINGR TYYDGILIVNKTTKLPSDYNPGEKPKAQRALQRMFTDAEKDGVSLYKISG FRSYETQVNLYNQYVARDGEQAADRYSARPGTSEHQSGLSYDVGAIGSAC NLREQFGETKEGQWIARNAHRYGFIIRYPKGKEQITGYQYEPWHLRYLGK NNAAKVQHSGQALEEYVRYKDRSES >SH2424 MLTIKKIFNIIGGELKDAHNKEANEINDFETIYKFVNSKKTAYFSPNKET WSRELGRNKNALDGNDLVNKENGEIGLIITENYISDLKFEIPQIIVEDSV QAFKQLAIYIRNQYTNPVIAITGSMGKSSTRMLITSLLGDYNVLENRGNN NVRAAIYNNMLKLIKNPDFAVIETSMNAINYLENTSTFLKPDIAIITGIG EAHFSTFKSVKDIAKIKTRIFDGLSSTTGVAIINKDTLYADYLIDKAHEN ASNVLTYSINKDAKADLTVDNIKYNKGSIELSITNQENKSEIYRLNTISE GMVSNTLASILTLKSLNLPIKQELLNDFKPFSKILALKEIHAKTHKLTLL DDTHNASLPAMINAIRAFNSQTKFYSGHKIIAIGKISDLGRKSNETHLKL VEELENSNADYILCKDNELRQVVNKVRNKNITWYPNKELLINDLKYLCNE DSLTLLKSSVTGTDFPEIAKNLPNILRDNNIEFDFDDLFKKLSEVGKSYI KINNKTGEIVEEYNSGLSQTIEGMGPLIYYLKSIDEKLENRIINLKSWPT NNAKKGYFEGLEIKTYTLLENMTESPYPSEIYELANELFKNHAERKHYIN NLIKELKLSTSIATNLTGRFRIKDRQSYTVKDLFEIYKHYKYDLFKFSNS FVLGLKYKSGFIRGKEETIIFTSYNDLEYLKSTIDF >SH2333 N-acetylmuramoyl-L-alanine amidase MMKTQAEINKRLDAYRKGTVDSPYRVKVWTSYDNRFYPMEPGCIDVDKSF HAQCADLTIDYILWLTDNEFRIRGNAKDAINPKKNKLPEGWKIVLNRPST VPRKGWIAVFTDGTYWEYGHIGMVYDGGNTSRFQILEQNWNGWANKKPSL RWDNYYGLTHFIVPPVAKENKAVSSSKQQAPKQKVKKASTKKALPKITKH ITGYNMDKRGYNPKGVVLHNDAGGMNYKQYYNNLVNANYDRLARGIAHAY VDRTGIWEAIDESRIAWHVADGTRPGSGNHDFYGIEVNQSLRASDKEFLE NEQAVFQFAAEKLKKWGLPANRNTVRLHNEFSQTSCPHRSMVLHTGLDPL YHSITEHARLKLKDYFIKQIRAYMDGKKPTSKVVVSKPGSASTPATRKDA NGYRENPHGTLYKEEHATFTANANIITRYVGPFTNMPQAGILKAGQTIIY DEVMKQDGYIWVGYTAYNGKRVYLPVRKWNRETDSVGKLWGVIS >SH0041 MTIYNLNFGIGWASSGVEYAQLYRRNIFKLMKENFKFIYLDFIQKENIQT LTENLGFEDDEIIWIYQYFTDIKIAPTTYTIQNIIDRLEDTNVEIERVNN KIKKIIFGNDNNYIRCYLKNESENIVDRAEYVSKGKLIKKEFYNFTIVFT EYYAPYEKKAKLYLRTYFNEDGSIAYEEHISGKNSIFVFPNVILYSKLEF IAYFLRQLNLTREDILLIDRSKNIGQVILENKNQARLGVVIHAEHFNHSN TNEDYILWNNNYEYMFNHVDYIDFFITATDAQKQLIVNQFNQYKNKNPKV YTIPVGSLKELKYTHERASNSIMTASRLAKEKHVDWLIESVVQAHKTRPS IKFDIYGEGAEKNNLQKLINEKEANEYIKLRGHKNLEEIYKKYQLYLSGS TSEGFGLTLMEAIGSGLGIIGFDVNYGNTTFIKDRYNGYRIPESIKNQGT KEIATKFAEKIDEYFVSSNKIDQMSHESYLIADDFLLNNCKEKWLSLVNE VQDD >SH0297 MCTGFTFQAKNGDVILGRTMDYDYPLSGHPAVQPRHYYWESRVDYKGTTT YGFTGAGSDMEGFIFGDGVNEHGLAISNQYDRGYASYANKIHDGYINISQ TEVLTWVLGYNKTIEELIEQADQVNVVAHTLNDINEAPPLHYHVSDATGR TAEITFVEGRIVLHDNPVGVLTNSPDLNWHYENLKNYANVTPYKPQYKRY KNLYIGNESGTSGLPGGYTSAERYVRAAYLVSNMLPDDGDDAVLDAFRIL DSVSIPKGAVRPSEDEFHYTLYQTVFNLTSRTLYVKYYNSNRIAELQLTE ELLNSDDLVIFDPIPQGLSTDKVN >SH2633 MNQVKNVLSSLFEPLTKIETYENLAIKIALIIIYIIVALIVIAILNKVIE QAFKIQNRSSKGNKKRSRTLISLVQNVVSYIVWFIVITTILSKFGISVEG IIASAGVVGLAVGFGAQTIVKDIITGFFIIFENQFDVGDYVKINSGGTTV AEGTVKSIGLRSTRINTITGELTILPNGSMGEITNFSITNGFSIVEIPVS VEENLDKVEKRLNKLFTAMRSKYYLFITDPVVEGIDSLDETKVTFRISAE TIPGEGASGSRILRKEIQRVFVQEGIKLPQPIYIKNNNQQGKS >SH0486 MKKTVIASSLAVALGVTGYALTTDNSAHASESTTNYAQLANLAQNNPSEL NAHPVQAGAYNITFVKDGFKYNFTSDGQSWSWNYTYVGGADTVATTQAAP AAQSTDYSASYSNEASTQSVSSNQQSSNTNVEAVSAPKTTSYSASTSSSS SASTGGSVKEQFLANGGTEAAWNAIVMPESGGNPNAVNPAGYRGLGQTKE SWGTGSVASQTKGMINYANSRYGSLDAAIAFRDNHGWW >SH1347 MSAIEWLFILLAIFLVLTLEAVNTAIECVVDLVTMDYHELAKQAKDIAAF SVMLVSIFALITGLVVFLPHIF >SH0344 MTVLLTGATGHLGSHITEHAIKEQVPDFNIGIRNPDKMPSHWKDKVGVRE LDYFNEESMVRAFKGIDTVIFIPSIIHPSFKRLPEVENLVSAAHKVHVSH IMFIGYYADQHNNPFHMSPYFGYAERLLASSGLKYTYVRMAMYMDPLKPY LPELADMQKLIYPAGEGRINYISRDDIARGIVALLQQPDKFGHRYLLSGY SYSMTELAAILSEAAGSKIEYSPVSLEKFSEMYDEPKGFGALLASMYEAG ARGLLDQHSNDFEQLVHDKPQTFPEFLKK >SH1721 MSKILLTGASGYIGGHLKDQLKIHHDIIATSRNTSNKENEENVTWKAADL FDLDEITEVMEGVDTAIYLVHSMMPNAKLTQANFEDMDALLADNFARAAK KQGVRHIVFMSGLIPNEDKLSAHLRSRLECEKILGSYGIPVSTLRAGLII GAKGSSYPILKRLVERLPGMVLPSWAYNMIAPVSINDVINKLALLVERTP QHNESFDITGPEIMNYKELIQRTAVVLNKRLPIVDLPIIPIWVSRYWVQL ISKVPKEMVYPLMNSLVHDMIPQPERTHPDISIGEMTYEESVQQALDEEN EMNENQNKSKKSSSSNSKEQIKDVRAISRFRIPENYSMEDVSKTYAKFIN NITLHLINGTINENEFNISLPFTNQFILKMERDMQDSSKDMIVYKIVGGN LALSNNGGNARFEFRRILDSNEAIIALQEYEPTLPWSVYKFTQANIHKSV MELFVNHMNNLADKDKEATTQSDQLFSTIAMTTGAVIGAYVGSKIYHLIK A >SH1468 MQTVLIIGANGKVSIEATKLFLEDSNFNVDLFLRNAHRIPDYASNRVTVY EGDAKNSKDLEQALDKVDVVFASLSGSLDIEAQAIVDAMSKKDVKRLIFV AAPGIYDELPAKFNEFNKSQFGDKLTKYRKAADIIEASTLDYTIIRPAWL TFKNETDYEVTSKDTQFRGTEVSRRSIASLAVRIAKNPELYSKENIGVNK PNTDGDKPAWFK >SH1454 MKIGITCYPSMGGSGIIATELGIKMAERGHEVHFITSNIPFRIRKPLPNI TFHQVEVNQYAVFQYPPYDITLSTKISEVIKEYDLDVLHMHYAVPHAVCG ILARQMSGKDIKIMTTLHGTDITVLGYDHSLKGAIKFGIEQSDIVTSVSH SLAHQTKSIIETEKEIVPIYNFVRENEFPTRHDETLKEVYGIKPDEKVLI HVSNFRKVKRIDTILETFAKVRKNIPSKLILLGDGPELLDMRKLARHLGI DSDVLFLGKQDQVSEFYQMSDLVLLLSEKESFGLTLLEAMKTGVVPIGSN AGGIKEVIKHDETGFIVDIGDSTSASEYALQLLSNKELYNKMQTAMLKDI DERFGSELITDQYEHYYRKMLNQKED >SH0207 MKRVIMTANFGAVGFSNKDKSSVTTEEHWTNPNEKGFSVYEKSKLIAERA AWDFVNATENHIEFATINPVAILGPSLNQHMSLSFQFVENIASGKMKRIP NIPMNIIDVRDVAQLHVLAMKTPEANGKRYIATADGQISMPEITQLIKKE RPELASKVSTKTIPDFAIKLGARFNSEAQEGKLLLEMNRNVSNQQARNVL GWTPSYTQEEAILASVDCMRDYHILK >SH0463 MQCPNCGQTYQQGDQYCGSCGNKLNGSLSQSTQSTTESFNSEIQSTSHST AIKQEQINGEQNHSEYDRGEFAHRYMSYEHRYAEGPFTIKVKSTFNESKQ LLKQAFTSHDVVMKGNKSFSITLLSSLVIIGLLILGMLLHLLSASLFDGY FVDTATIILKFVLTTMLALAFLFIVTFAVIRLMIVESISFKKILSDYILV NTLSVSILFLGFIVFFFEMYIFSGILIAFSVILLLTSSVYLISKYSVNHT LRFASFYSVMIFFVIIGFALHLFGSTIIHRYDDLGILHQLFWRWL >SH2280 MKTFFTPLRILIATLTLLVISFVCYIYAKIPTEPDTSKIETITAKPQYSL SFIGEQQPQESFTLYFNPSLGNVSSLLVKNDEIIHSDTPLFEYYNPILEK LIVAKKKALSSLINQSTKQSISQQLTLNSQILELQSRLQIRINSPISGKV TILEAHPSKLNTKIMQINSEKHIIRANITESQLEHIKVNQDVNVTRNHSK LFTGKILSIIQIPYKVEKGESIYQVDISTQDQYPLGRHFDIDVGTSKIEL PKNSIYENYYVLITQNNKIIKRRIEYTKSQNNGYIMVSNGLNIGDKVIVN PSSSLLQK >SH0489 MTKLESLLHASTGLSLISGYLMYNRRYLLSFDKKREGETTQSISVIIPAR NEEKRLPKLLKSLSQQSMRVECIVMDDDSNDRTAEIAREMGAKVYNVTYD NNGNTWIGKSYACYLGASYTVSDILIFMDADVELNNEHALEAIIQSYARQ QYRGLMSIQPYHVVYKPYEHLSAMFNLMTVVGTNSFSTLSKSKGESLAFG PVTVMNKSDYILTQGHKNAASHIIEGFSLGKAFQRCQLPVTRFEGQGFVS FRMYEAGFKTMIEGWTKHLAVGASSTQPHIMMLIILWMVGCITSFSGLAL SLFMKTLSFKRMALSYSLYTLQFIRLHRRVGRFSILFLAINSILFLVFIL VYINSYRHIHYTKQVKWKGRQFSIK >SH0122 MSQFKDTLYKLFEPMMKIEFYQNLLVNLLIILAYILIGMIVIAISRKLVT KFFNVNEKKKNRHKIKRSETLSTLIQNLISYVVWFIVLTSILSRFGISVS AILAGAGVVGVAVGFGAQTIVKDIITGFFIIFEGQFDVSDYVQINASGVT IAEGTVKTIGLRSTRIQSDTGEIYTLPNGMISEIVNYSATDVSPIVMIPI SPNENYKVIEEKLLRFLPTLKNKYDIFVSAPELLGLDSVDGNEMVIKLLA HVKPGMHFPGQRLLRKEVIQYFSEEGIHIPKPTLVKLDKELSKKE >SH2236 MKPNVLLAGGSGYIGKYISSVIEKDANIYALSKYPNTKKEDNDRIIWLKR DIYNYTDVVKAMEGMDIAVFYLDPNKNSAKLTQATARDLNLIAADNFARA AAQQGVSKIVYISGSRFDIETVQRLENYGVPVEKTNTQIKRPHINAELQM SKYDDIRTAMRMILPRKWTLSYLVDYFMKWLNDTRGTFMHTYQDNDRYIV YARKKSKPLLIMEKVEDDSGLITLHLISGSMIKSNQKKQGKLEFRQIKGT RLVIVHLYDYIPKLLWPIYYFVQAPLQGLIMRGFEIDCRIKHFNGRVQSG EKMKYTK >SH2229 MKKLAVAASVATGAVAVLSNHNAEASTQHTVKSGESLWSIASKYNTSVDS IKKSNNLSNNMIFPGQVISIGGSSNNSNNASSNATTSSSTYTVKAGDSLY AIASKNGVTVNALMEANNLSGYLITPNQKLKIPNGSTTTPSKTNPSTNNN VGGSGGYSSPTFSHQNLYTAGQCTWYVFDRRSQAGKPISTYWSDAKYWAG NAAADGYTVDHNATVGSIMQTTTGYYGHVAYVERVNADGSILISEMNYAN GPYNTNTRTIPASVVSSYNFIH >SH2547 MNKKILATAVLGTGALSTLFAHQAEASTTHTVRSGESLWSISHHYGITVS KLKSLNGLSSNLIFPNQVLKVSGSSNYSSRSNYGNSSSTYTVRAGDSLSS IASRYGTTYRHIMNLNGLNSFLIFPGQQLKVSGSVSSNSHSSYNSNSGGS SSTYTVRYGDSLSSIASRYGTTYQHIMRLNGLNNFFIYPGQKLRVSGSAS SNTYSTRSAQSTYYSSPVFNHRNLYDWGQCTWHVFNRRAAIGKGISTYWW NANNWDNAAARDGYRIDGNPTVGSIAQSDAGYYGHVAFVERVNSNGSILV SEMNFSASPGILTYRTIPAYQVRNYKFIH >SH0239 MQIIKQDGSILHIYFENPINKIEKLYIKNEFNSLTLEKTNGDLHFKIDLV EVAKQFIQYENKKIYIIVEESTPILTTQSNLKVTNSQSEVSGLTEVLIDD SENIKIQPYITRNGYLHLSLDDVDLNKTYFSRRHIDTLKINNSEAIIEGQ FATLNSTLKDVQLLIKTRLTDREKFVNINLEEIGKTKNASTYNFSVDIYK DLIEFMKYEYKNEDIIDIYLSIKVLESSENLRIKIGNPRIMAEKLLKGEI ITEFNGNIVSLTPYFTMKGRNLSFRINTYDIDSYLTYVDELKRPKRPNFL KKENQKIWVIGEKSYKAQDNGYHFFKYMRTYHPDKPVYYIIEKDSKEAEN VLPFGNVIFYNSAEHFKIMIKADYICTTHHPELIYPTTSDIYTRKIKAVK VFLQHGVLGTKNLSNINGNQLKDFNVDLFITSSSREKEIVVRDLNFFSNQ VAVTGLARFDELFNPNVEVKNQILIIPTWRDWLTSIDRLQTSEYLKRMND LLHSQKLKEIANKGTDIIFCLHPNMQPFIDYFDVPSYVTSIKQGDIDVQK LIKESKLMITDYSSVAFDFSFLNKPVIYYQFDRNEFLGKEASHIDIEKEL PGIIVNAQDKLERELDNIQKKQFKIDEALEKRIDRFIAYKDRNNCERIFD SITNFRETSKVKSKIKYDILSQHAVNRFRKDKKYFKVMEKFNTGLTRLLP VKKDLIVFESNVGKLVGDSPKFIYDELKKYNKKYQIVWATNTLYPFNDPN VKTVKRLSPEYFYYLSRAKYWINNQNFPHYLRKHKDTIYIQTWHGTPLKK MLNDVETFQGRDANYKNRVNQAIKNWDYLISPSPYASACFKTAFDFQKEI LEVGYPRNDVFYNVENTDMTEKKKLIKQKLGIEGNKKIILYAPTFRDDEI NKAKKHIINLKLDLPRLKESIGDEYILILRPHIIISNALNLSESLKDFVV DGTKYPDISDLYLISDICITDYSSVMFDFANTKKPLLFFTYDLEFYKNKL RGFYFDFEKEAPGPLIKTNDGLIEAIKNITNVQEEYDDKYQVFYNRFCTF EKGIASKTIVDKFFKQDC >SH1036 MLINAQDYGLKGCNKRKDTKAIQRALNKARYGEHTVLIPSGTYYISKALI IYDSTTLLLEDDTTLLRCGKDALLKNGHRFGFYKGYQGNSHIYIKGGTFD MNGSKYPYNNTAMSIGHAEDIQLIGVTVLNVVGGHALDACGINGLYIKNC NFKGFNDFDGDRSFSEAIQLDIQVPGAFPKFGTTDGTITKNVVIENCYFG NSDDHQMRPWNRAIGSHASRYNKFYENVHIKDNCFEGTEDYALTPLKAKN MIISRNKFKNCKGGIRFLGVKDGKNAADPVTGKVMESQAGENFSVIGNHF IGEMKKDAIHIRSYNNVKHQQVFIAGNTFDKASQTIHLEDIEDLTLNQGE DVTIKKINVD >SH2251 truncated poly (glycerol-phosphate) alpha-glucosyltransferase (teichoic acid biosynthesis) MKFEDTINPNSQKVSKRKVFTLNGRLHKIDYFDDVTAIKIKEEYYDKKGD VYLKKHFTNDEENKLIDIEHLTKRGETRTFNNEKALFTYYYNHVLPNGSV VFNDARLLDRPLIDCENDIKRILMFHSNHIQGNKVCHSYKLALDKQEIID KYIVLTEYQKHDIQSQFGIDDNKIDVIPHFVSIAQSNRRDEVEDQFCFIG RLAQEKQIDHIIKAFDIYLKKGYSSKLLVYGKDKEGNLNTLKQLVKTLQL EDKVIFKGHTNHPKEVFSKVIASLLTSRYEDFGLSIMESINYGCPVISYN VRYGPSELITNHENGILVKKDDIEGFADAMEMARNIHFKDVKLSEKFSVE QASNNYQSLIDDVTHAENK >SH2629 MFKKTTSSIACLTIMATSIGALNANASEQTEGSQKGTMGYGYQKYLKNHP NEQSNATSNRSTFSTKSKAITTQNGDRVLDISEWQGNLTDSQVKQLKKDY DFIIIRGQYGSEYVDQCLENNSALLDKNNMKFGVYSYSLYENADDARNEA QTLYSRAPKASFYVNDFEQNSITSGDADTATKAWADEMKQLSGNKKVLFY SYENFMTNNVPNAVSAYDGYWLAAYQEQEPNREKVLWQYTDSYYAPELNQ NVDANYIDANVTADWFTS >SH1652 MSYLITIVSFMIVFGVLVTVHEYGHMFFAKRAGIMCPEFAIGMGPKIFSF RKNETLYTIRLLPVGGYVRMAGDGLEEPPVEPGMNVKVKLNDKDEITHII LDDQHKFQKIEAIEVKQCDFKDDLYIEGITSYDNERHHFNIAEKAYFVEN GSLIQIAPRHRQFAHKKPLPKFLTLFAGPLFNFILALILFIALAYFQGTP TTSVGQLADHYPAQQAGLKSGDKIVQVGQYKTKSFDDIQSAANKIKDNKT TIKFERDNQTKTVDITPKKQVIKQTKLNSETTYILGFQPEKEHTLIKPIA LGFDQFVSASTLIFKAVGTMIASIFTGQFSFDMLNGPVGIYHNVDSVVKQ GIIALTYYTALLSVNLGIMNLLPIPALDGGRILFVIYEAIFRRPVNKKAE TIIIAAGAIFVLIIMVLVTWNDIQRYFL >SH2450 MERIVITGALGQIGTELVLKCREIYGNDNVLATDIREPEEDSPVNNGPFE VLDVTNREAMMAIVENFKADTLMHMAALLSATAEKNPLLAWDLNMGGLMN ALETARTYELHFFTPSSIGAFGDSTPKKDTPQNTIQQPTTMYGVNKVAGE LLCQYYFTKFGVDTRSVRFPGLISHVKEPGGGTTDYAVEIYFEAVRKGRY TSYIAKDTYMDMMYMDDAIDAIIKLMEADSDKLVTRNGYNLSAMSFEPEQ IKAEIQKHYPGFALDYEVDPVRQAIADSWPDNIDTSYSRKEWGFNPKYDL AGMTELMLKAIEEKEQNK >SH0303 MFGKFVKGIGIITTISLLHTSISDASESPVTIANKEKNSSISTKYQPSGV MLTTDQGQILYNYRGNNQVDPASMSKMMTLYLTYEAIENGKLKLNDKVKI TNKYATMSNLPNLSSVSLKQGQTYTIEELIKQTTLASSNAAAMILGEKVS GDNNTFTNKMNQQAKSFNMTNTNFVNPAGAQNSLLDQYAPSKFKKQDFPK STAKDMNLLMQALIKKYPQILQISKLTRDTQRGNTFKSTNLSLKGQPLYL PGTDGLKTGTSNKGYNIALTNKQDQLRLNETIMNVKPFGDVNAKYNRNRI GNQIIKQYRQKYEYKKVLTEGDHEIDGNKYHVKKDLYDVVPKDKSKWHLA INSKGKVYVHYYRDFLPGSHYPRVAADKKWKWF >SH2419 MSQFTNYKLILEELDRTLSHVQDEQYDRFANDVNGAQRIFTAGKGRSGFM ANSFAMRLNQLGKEAFVVGESTTPSIKEHDLFVILSGSGSTEHLRLLAEK AQSIGAKVVLLTTSPDSPIGELAETVIELPAGTKHNVEGSEQPLGSLFEQ SSLLFLDSVVLGLMETFDISEEEMQNNHANLE >SH0518 MTLIQAILMILLTVVMYFAAKKLQQKYDNPFLNPALVGSVGVIIVLLLTH QNYHDYMTGGKWINHLLNATVVCLAYPLYKNRHKIIENLSIIFSSVMVGV ILNFVLVFTSLNLLGYDEETIVTILPRSITAAVGIEVSQELGGTDTITVL FIITTGLIGSMMGSMLLKVGNFKTSIARGLTYGNASHAFGTAKALEHDNE SGAFSSIGMILTAVISSILIPIMIILFY >SH0206 MKEQVLVTGGTGFLGLRIVAELLKQDYSVRATIRSLSKKDTILETLKAQN IDT >SH0692 MKSFTFFMHNIYALGGTVKAVSELANTLADKGHHIEIISVFRAQDEPYFK INDNIKIKTLVDYRLKPQNTKAIMMNRLNKYTSLLKPKEINQFEPGLNQF SKYVEHKMIKAIKKVDTDVLVGTRASFNILISKYHSNDVITVGMEHMNLH AHPENYQQDILTAYRNIDLVTTLTQQDQLNYEQQIDTPVYTIPNIINPVK HATKKENIIISAGRLEFEKGFDILIESVRRIQNDLKQLNFKVEIYGDGQE RGHLQQLIDQHQLNDLITIYPATQQLNTKLSNSKITVVPSRNEGFGMVLL EAMAQDNIVISFKDTLGPASIINHNSNGYLANYGDAGSLAKYIDIAMNHV DEASQMINEGHVTLKQYTPNTVYEKFMTAINNV >SH0140 MAKLVSIIVSVYNKEQFLEKCIESLIDLKMDKNNIEAIFVDDCSTDESVN IIKHYEKDYDFIKLIQLPENTGSPSEPRNIGMREAQGKYITLLDADDWLD KEGFPQVIEKVNKDDADLGFGQSFKHKSKNVKYHARFTSYKEASHLKPQD ISKIFRAVGPPGKVFKRSLVMDHHIEFEHMKYGEDKLFFFQLFGKVDDIT MSTIPMYHVNRYDENKSLVQQTSMLDKANSNLEVLDRTCHMDMSSELKHM ALARMVEVDFISRFLRTKTFIKSADKEKFYAVIEKVERKIKEQGIDINTL ITNPVFKQIYTLYHHADESVFVNFTKDVVNDQWRYIIQDGIVFRDFVHQY DMIKPTVVDCYPVYEGTQMMGENKYEVIRVMKPDDINIQSVSLVEINNAA NEYEVTYKYSDDRIYVPHEEFEKLNKDININFNVNYGESGRSLVYASYPS FNDVFKMKRQNFKVEFVHKKNENKAQQVTNRKSEYFKRITNPMMTLKKIK IYKDVSFKEEVGSLEAGTRVEASDIQYTSKGTPRLVLDDGSIITANKDFI TLINTSGLNKYITEVPKKVKVVKACKLYDSRDFKDNTVRKLKKGDVLTIR DIIYTNNSTPRLVTQEGLFLTANKDFIKIIK >SH0690 MIKQINISNMRHLALQLNKAKSAGFSHFIPYSNDIKINHDMLEAIDLTHN SIAVDYTLNGLYLNDCRYFGEDTLTFLSWMKNINHYPNIIFNIDRALLHL SKYDIQSIMDLAVISVLKDEIDIDNHVVFDFINECRTSHAFWASLDTFDI KKINHFDLNKLAYIHGHSIPYSKFRYPGKEEEMRFVDSWLVTTKFKLPKW LYNKMQNRALNKHRNLSYVYDKDSSKVKNHVVFLGFDYGYRGNSKYLFNY FVKRNPTTEAYFITNDRRGPYFLPTDAENNKELIETAKIVVIESYIPDDF KPNGTVIQLWHGTPIKKLFLDSKEPDQNKNIYNYKARKYNKWLKQDYLLT DSESAEGLFETAFPNQHTQMIPYGYPRISYLLHYQNDKNHQKKIKDALNV DRTKPILLYAPTWHATKDSTELMSISPELIEEYHVIFKGHIEDDMTLPEG AIEAPNHIETQDLLLISDVVITDYSSIIFDALTIGKKVCLYTPNHSSYQQ ERGVYDDVMESLSKVWYTDEDLLHNNLIHHTLTDISKHQLVNRNNTSLKR LTQLMRDIINNK >SH0096 MKSLIIGANGGVGQHLVRKLKARDVDFTAGVRKEEQVEALKADGIDATYI DVAKQSIDELIELFKSYDQILFSVGSGGSTGDDQTIIVDLDGAVKAIKAS EQIDHQHFIMVSTYDSRREAFDASGDLKPYTIAKHYADDYLRHANLKYTI VHPGALTNEHETQQFNMSAQFENVQNPSITREDVAEVLVSVLTDEVLQGH EFQIINGDLSLLDATTKYLEE >SH0618 MTKIFITGATGLIGTRLTKRLVEEGHEVAGFTTSERGKEKLERLNAKAYI GDILKADTIDAAIGDFRPEIIINQITDLKNVDMAANTKVRIEGGKNLTDA ALKFDVKKVVAQSIGFMYEPGEGLATEETPLDNHSDGDRKITVDGVVGLE KETARMDQYVVLRFGWLYGPGTWYGKDGMIYNQFKDGEVTLSDGVTSFIH LDDAVEVSIQAMNFDTGIYNVADDEPVTGSDFAAWYSKEVGVDPKVTIQP AQPFERGITNDKFKEQGGTLIYNTWKDGMHPLK >SH2316 MIGKCGNSGNSSEPHLHFQVMNTSKIDECVSLKIKFSNGRSPIKGDSI >SH2179 MSLHKKKISLFAFFLLTVFTVTLKTYFSYYVDFSLGVKGLVQNLILLMNP YSLIALILSVFLFFKGKKAYWFIFIGGFLLSFLLYANVVYFRFFSDFLTF STLNQAGNVESMGGAVGASFKWYDFVYFIDTIVYLFILIFKGSWLDKRVF SKKFVPVVMAASVALFFLNLAFAETDRPELLTRTFDHKYLVKYLGPYNFT VYDGVKTIQNNQQKALASEDDLTKVLNYTKQKNTTPNSEYFGAAKKKNII KIHLESFQTFLINKKVNGKEVTPFLNKLSTGNEDFRYYPNFFHQTGQGKT SDAEFTMDNSLYGLPQGSAYSLKGDNTYQSLPAILDQKQGYTSDVMHGDY KTFWNRDQVYKHFGIDKFYDATYYDMSDDNIVNLGLKDKPFFKESAEYQS KMKGPFYSHLITLTNHYPFTLSEEDADIDKPNTGDSTVDGYIQTAHYLDQ ALEEYVTDLKKKGLYDDSVIMIYGDHYGISENHNNAMEKLLGEKITPAKF MDLNRTGFWLKIPGKEGTVDKTYAGQMDVMPTILHLVGIDSKNFLMFGTD MLSKDHNDVIPFRNGDFITKDYKYVNGKAYSNKTNELLETQPKDLDKNKK QVEKDLEMSDNVLNGDLFRFYKNPDFKKIDPSKYEYKTGPKGNQK >SH0332 MTVYNINFGIGWASSGVEYAQAYRSKLLREINQPAKFIFLDFISAENIQT LTDNIGFKDDEVIWLYQYFSDIPIAPTTYTVDDLKKDLGNPVTAQVVTGK TMRLYIGNDKSYVSCYLKNEDDIIVDRAEFVVNGMLVRKDYYSYVRTFSE YYAPYENRAKLYKRQFYNEDGSIAYKEYIDGESSVYVFEDARLYSKQEFV AYFMKKLHLTEQDIVIIDRSTEVGQSILEHKGSSKVGIVVHAEHYSENAT NDTYILWNNYYEYVFAQAPYIDFYITATDLQNQVLSEQFQKYTSHQPRVR TIPVGSLHQLSYPIGERKRYSMLTASRLASEKHVDWIAKAVIKAKKKVPK LTFDIYGHGNERSKIEEIIKENEAQDYIQLKGHKKLDEIYVNYDLFVSAS TSEGFGLTLMEAVGSGLGMIGFDVNYGNPTFISHGENGYLIPIDKDNQDV EVITNLMAEKIVQYFNDGPKHSHEKSYKIAESFKTEHITQKWQNLIDEVL YD >SH1271 MQKFFKNNKLIVVFCAVIIFIALIGLSLRSHTQSPPEQYVGDSVSLGQRV VSYPVNFVTGAINNLFSSNKTTDNKKIKQLEAKNEKLEAENKDLKKELDM TDISKYDPISGAVIARNADQWMNTVIIDKGNKDGVKSNMAVMTAEGLVGR VTKVNQFSAQVDLLSTNTRTGKLSVNIQHDSKNVFGLIDHYDKKNQELII GNINNKNKISKGDKVVTSGLADQLPSDLYIGEVTKVENDEYGLAKEVRVK TGANLSDISHIYIAKKDPDNASDESRDN >SH0375 MVKYYVSCLVLFFTFAIICGMALAEDVTDEASVVAVGDNLIHPVVYNDAL QQDGSFNFKPMYSHIKNDIQSPDLAFINQESPIGGDNRPFSGFKNFNTPS QIAQDVVETGFDMVNGANNHSLDQGDEGVLNHLKTWNKFDKQVLFTGIFN SEKDAQTIPVMTVNGIKVSLLSYTYGTNEMTSQYPYTIKKFNEKTIQRDV SQAKKQSDVVMVSAHWGLENHHEPNRTQRKYAQLFANEGVDVVIGTHPHV IQPIEWVKSEHGHHQTLVAYSLGNFLNGQDTGNEHNQLLGRLNFDIVKAP KGAHIENVKWTSMVNHYQQWDETDKDTRHDFEVYNLDDYNEDLAQQHGLR HDNKSQWNVKHLQDITKDVIDSDYLDEKSI >SH1942 MVTQNKKILIITGSFGNGHLQVTQSVVNQLNEMNLSHLSVIEHDLFMEAH PILTSICKKWYINSFKYFRNMYKNFYYSRPDELDKCFYKYYGLNKLINLL LKEKPDLILLTFPTPVMSVLTEQFNINIPIATVMTDYRLQKNWITPNSHR YYVATDDTKRDFVNAGIPASDIKVTGIPISDKFESDIDKVAWLKKHNLNP DKPTILMSAGAFGVSKGFDYMIDNILQKSPQSQIVMVCGRSKGLKRTLEM QFKSYDNVLILGYTKHMNEWMASSQLMITKPGGITISEGLTRSLPMIFLN PAPGQELENALYFQDKSYGKIANTPEEAIDIVSDLTNHEYRLQAMTNKMT EEKVNHSTYRLCTDLLNILDSSSQQQEIYGKVPLYARFFVK >SH0040 MNKNSKKKLDFLPNKLNKYSIRRFTVGTASILVGATLIFGVANDQAEAAE NNTTQKQDDSSDASKVKGNVQTIEQSSANSNESDIPEQVDVTKDTTEQAS TEEKANTTEQASTEEKADTTEQASTEEKADTTEQASTEEKADTTEQASTE EKADTTEQASTEEKANTTEQASTEEKADTTEQASTEEKADTTEQASTEEK ADTTEQASTEEKANTTEQASTEEKADTTEQASTEEKADTTEQASTEEKAD TTEQASTEEKANTTEQASTEEKADTTEQASTEEKANTTEQASTEEKADTT EQASTEEKADTTEQASTEEKANTTEQASTEEKADTTEQASTEEKADTTEQ ASTEEKANTTEPLTDNQDESTEDESIEAKKALLTEYVTSNSDVSEEEAKA EIQDIDLQDVDFSNANENTLLSTLVKNISNKKEEDEKLATPRAISRIASP VMLAATDNVAAQESGTNVNNKIDVTSLQTDKNTVRPNDGEGFSVTSTFKV NGKVNEGDYFTVDMPDYANFNGIADYTAVDNKIYPTIKDGEQVVANGVYD VDTKKLKYTFTDYVNNKQNIEGGFKLPQYIDRKTATQSGDYNLNYNVAGN EVNIPISVQYDNYRDGHVIANATSLITNADIFNTGSHEYTQYIYVNPQSV NSYDTWLTIQGYQNQVNDSSAIFNSNDTSIEIFDAESSSNINPSFYVNDS NYRNVTSNYQINETGDKQAKIYFGHIDHPYIVKVTSKIDPNSTADLKTRI RMDNKNYRGTTDYYIHDNTVERSGANGIAQGDEALYNLGDYVWEDTNKNG IQDSDEQGIEGVTVTLTRPNGTTETTTTDSNGKYQFSDLQNGSYVINFQT PEGYTPTKSYQGMNTEVDSNGLSTVGIINDADNWTLDSGFYKTPVKYSLG DYVWYDSNQDGIQDYEERGIEGVTVTLTHPDGTVETTTTDSNGKYQFDNL DNGDYTVHFEKPTGLTQTVVDSGNDDAKDADGETVKVTIKDHDDFTIDNG YFESTSDSESQSDSESTSDSESTSDSESQSDSESTSDSESQSDSESTSDS ESTSDSESQSDSESTSDSESTSDSESTSDSESTSDSESQSDSESTSDSES QSDSESTSDSESQSDSESTSDSESTSDSESQSDSESTSDSESTSDSESQS DSESTSDSESTSDSESQSDSESTSDSESQSDSESQSDSESQSDSESTSDS ESTSDSESQSDSESTSDSESTSDSESTSDSESQSDSESTSDSESQSDSES QSDSESTSDSESTSDSESQSDSESQSDSESTSDSESQSDSESTSDSESTS DSESQSDSESQSDSESQSDSESTSDSESTSDSESQSDSESTSDSESTSDS ESQSDSESTSDSESQSDSESTSDSESQSDSESTSDSESQSDSESTSDSES TSDSESQSDSESTSDSESQSDSESTSDSESQSDSESTSDSESQSDSESTS DSESTSDSESQSDSESTSDSESQSDSESTSDSESTSDSESQSDSESTSDS ESTSDSESQSDSESTSDSESHSDSHLPDTGEEESNKSGLIGAGLAALGGL SIFGRRRKKNSEQ >SH2383 MKISGQAQYIKETNQEKFYNGTTGFQAGEFTVKVKNIEFNDRENRYFTIV FENDEGKQYKHNQFVPPYKYDFQEKQLIELLTRLGIKLNLPSLDFDTNEL IGKPCHLVLKWKFNKDEGKYFTDFSFIKPYKNGEGIINKPIPKTEKQKAE EKSNSQQTPMTSQDNPFGNNDPLGYEDDLAF >SH0890 MSLLVIGANGGVGSKLVKQLKEDQVDFTAGVRKNEQIETLKQDNIEATLV DVEKDSIEDLTETFNGYDKVLFTVGSGGSTGADKTIIVDLDGAIKTIEAS KQANVKHYIMVSTYDARREAFDPSGDLKPYTIAKHYADEHLKNSGLNYTI VHPGALEDKEGTSKIETDLYFDGKGSIPREDVASVLKEVALSENKFINKE FQVITGNQTISEALSSFE >SH2136 MINKTLTVTLTSIAALAGLSGLANAQEYTNSTHTTSQQSNTYNSQVEQET NLGLTNKDIVKVKDGDTLYQIALSHHLSLEQLYNFNPGVTALIHPGDLIA VSEKGAAKLENKEINYAQTYAETTAFNQSDVVAQSVSASTTNVTGYNIVP TSAPTNTMHDSYHSSVNTPVSYQHVTTANQGNRYSFGNCTYYAFDRRQQL GRSIGSYWGNANNWAYSAKNAGLTVDNRPEVGAIFQTTAGYYGHVGVVEH VNQDGSVYVSEMNWNGHYNRVTNRTITNTSSYNFIH >SH0275 MNDKRKKNNYLVYGISVAIIILITAMAGIFPKAFGANAQHIYNFISNSFG WLFLLIIFILDIFLISLAISRYGRFKLGSDDEEPEFSFLSWLGMLFSAGL GVGIVFWGVAEPLTHYLHSPFPKDVPNQSAESARVAMGYTFFHWGISQWS IFAMAGLIVAYFQFRKKRDGLISTAMEPVFGQAYKRPFRNVIDILAIIAT VMGIATSIGLGIMQISGGLNHVFHVPNNNVTKIAITVLMVCIFLGSAITG LNRGVKWLSNINIILGAVLLLFMLIFGDLKFIFESYTLAIGDYIRHFVEY SLRINPYSGNNAWIQQWTVFYWAWVISWSPFIGGFVARVSRGRTIREFIM CVLIVPPLISFVWIAGFGGMAVKVAMGGDNIAKLVDKDYTVALFELLSKF PLADITSILAVVLIFLLIVTSADSTTHIVAGMATGGSENPKVKHKVIWGL LIGAISVAMTIAGGLTSLQTASVVTGLPFSIILLLMTLSIMRALRREHTK HFQMSYIDDDKDYSIPLEQREDHNKSNEKEQGKEQNNEEE >SH1173 MAEQDGQKLFLKRNSNPFIAALSAEGIVPKLVWTKRIETGEVVTAQHWKN GRELEPDEMYQSRVAALLKKIHGSKPLLNMLKRMEMEPITPNIMLKKINA SLSREVLTHHIIRKSLTYLEEHIPNLDSRFFTVVHGDVNHNNWLLSDRDE LFLVDWEGAMIADPAIDIGMLLYNYVPEKNWSDWLKTYGVEESIELNKRM KWYTVIQSIGMVQWYEEQKRFKDMNNWLKFLNEVMNSNLFI >SH0961 alr1, alanine racemase 1 MSDKFYRSTYLNVDLSAILNNYNTVRTLHSDKTVIPVVKANSYGLGSVKI AQHLMKNGADFFAVATLDEAIELRMHGINAQILILGVIPLEDINKAIQHR VALTVPSLQWLQHAIELISDDNEKNLWLHVKLDTGMGRLGIKSLEEYKEV IDLIQSHPHLVFEGVYTHFANADEPGDLMDHQYEQFETLVTQAEKPKFIH SQNSAGSLLRNFELCNAVRLGISLYGYYPSAYVKEKVETELQPSAQLLTQ VVQTKYLKVGESVSYGSTFTATEDIKIAILPIGYADGYLRSMQGAFVNVK GHQCEVIGRVCMDQMIIKVPDDVKEGDSVTLLDNAYDSPQSAETLAQKQD TISYEVLCNLGRRLPRIYQVDDEMHVTNELLK >SH1512 alr2, alanine racemase 2 MTAIWSVDKEAFLQNAIKVKNGNSIMAVVKNNAYHYGLEFAVTSFLKAGI NTFSTTSLKEAIKVREIAPDATIFLMNAVYDFEKVRHYQIQMTLPSLAYY YKYKNDLSGIKVHLEFENLLHRSGFRTLEEIREVLNDHHINSNEDKMIIS GLWTHFGYADEFDVPEYSIEREAWLNIVDTLLDEGYHFDLIHAQNSASYY REGQKLLPHHTHARVGIALYGSRPYSALNEYSIKQSLTVKGNVIQVREVN AGDNCGYSFAFEATRDHTRLAVVDVGYGDGILKSRAKHEALIKGKRYPIR ALMMSHMFVEVDEEVDAQDEVILYNNDIRIDEYTFKGVGANSEQLSAMNH DSLIKEYR >SH1911 atl, autolysin MKKKFNLKFPSMIAITLFGAAFTSQHAHAAEANQNSNNTNNVIDDQQNIE NAEQAKKEVTNSAQNVSGVQTYQNPSDVKASVATVSKTYDAKLDNLATTQ QTSQDQQSTQNQSTANTSATNSNSELAKVQDNEQEVSTSNKSDQTTNINN THSNTDANKQTLQASKNALSSSQVQSNDDTSANSNQNTTQYVNNQIDESS SNSQQENSLTSSNKNQLNSSSVTPSQSNQVAQSNNQIESKQSSDKKVSTY SNNDNNATQVNVDQAKTSQEANTKNASASKTTQTSTSNSTQSGYSGFRSV GGKGGPATSVKTVKRYAAKATTSSLPKYKPQVSSSINNYIRSNNLQAPKI EENYSSYFPKYGYRNGVGKPEGIVVHDTANDNSTIDGEINYMKNNYNSAF VHAFVDGNRIIETAPTDYLSWGAGPNANGRFINVEIVHTHDYASFAKSMN NYADYAATQLQYYGLTPNSAENDGQGTVWTHYAISRFLGGTDHSDPHAYL QSHNYTYNELYDLINEKYLIKTGQVAPWGTTSSSSSSSNTNKGGSSNSGS TTTSPKLTVKSNSGLAQIKTDNSGVYTTVYDDKGKATNQVHNTLSVTKSA TLGKDKYYLVSDYNSGKVYGWVKQGETVYNTVKSPVKVNQSYNIKSGATL YTVPWGNYNQVAGTVSKSNTAPFKATKSQQVGKATYLYGSLNGKNGWVSQ AFLSNITKPSSGSKTPTVDNTLKVSNLKNTLGQVSTKNKGTYTTVYDKNV KANATIGGKTYNITKKATLNNKDYYLISDYNGNTSRGWVPASEISVKTTT PNKTNATYYDINGNANIYDTPWGTAKQVKATVPSSGKQLKSIDNLKVGNE TYLHGVINNIWGWIKSTDVKQTPKVNAKFAVNTKATKPSTASTQTVSKVA QVNANNSGARATVYDKTGKNATKYANRTFNVSKEKTIDGNTYVLLQNTTT NTPLGWFNVKDLKVQNSSSEQKTSGTYKINNKNNGLYSIAWGTNQQRLDN KDLANKSFKVSKSVVIGNTTYLYGTVNGKTGWIAKNDLTSSNISSDNGEK YQYEFIINTTNGYYYDDPSSAKATSLKAFNEQIFQVTNRKVVNGKTWYYG KLSNGKYVWIKDTDLKKELVKYSKSYRTLNQVVSLQQNAYGAPPQVQRNG YGWSNATYSEIKNAMNTEKLAKDDTLKYQFLCLDRPQNLSVASLNQLLKG KGVLENQGQAFSQAAATSGINEIYLIAHALIETGNGQSQLAKGANIVNNY VTTKSATKYHNVFGIAAFDANPLYNGINYAKQAGWNSVSKAIIGGAKFIG KDYIKAGQNTLYKMRWNPDHPATHQYATDINWANANAQYLKQLYNEIKAV GKYFDISSYSK >SH0388 capA, capsular polysaccharide synthesis enzyme CapA MENKLDLSNIFKIIKKNWGIWLFIPIIFLLISLIITFLFMTPKYEATTQI LINQKEKNKELMAQEVQSNIQLVNTYSQILKSPRILDEVAKKDNKYSSDE INNMLSIDAESDSQILNVNVESKNKKDSEKIANEIAKVVSDEMPKIMSVD NVTILSKATGTAHKVSPKVPVNIAVAIILGLLVAILIIILKELLDKRIKT EEDVERELNIPVLGSIQKLK >SH0390 capC, capsular polysaccharide synthesis enzyme CapC MIDIHNHILIDVDDGPKTKEDAIALLKQANDEGVTEIIATPHHLSPTFDN AYENVQQKLNQLSELQETKDLGIKLYPGQEIRISDQVLPQLRKGEAIGLN HSRYLLIEFPSRGVPHYANRLFFELQSEGYIPIIAHPERNKEISQNLDVL YNLINQGALAQLTSSSLQGIQGKKIQKISIQMIENNLVHFIASDAHHESQ RPFIMKSLYNNKKLKKYEKNIENLINNAKYIVNDEDVIKKQPTQNYNDRK LFGLF >SH0391 capD, capsular polysaccharide biosynthesis protein CapD MDKLSARGRLLILIIIDSLIVAFSVFICYNILEPFFEGYSRDLLIVNSIV LLISHHVFAYIFNLYHRAWEYASVNELLLIVESVTCSIITTMILVPIFTA HPPFFRLYLITWMMHLILIGGSRISWRVARGFVVGKKLKKKPTLIVGAGR GGSLLIRQMLRSPEMGLEPVLVVDDDPQKKKLTIAEGVKVQGSIDDIPNL VNKYRIKRIIIAIPTLKPDRLKEINNICNSTGIELFKMPSIEQVLVGELE VNQLKRVEVEDLLGREPVELDMAMISKELTHKTIMITGAGGSIGSEICRQ VCKFEPERILLLGHGENSIYLIHQELNAIYKDKIEIIPIIADVQNGDRIQ EIMDKYKPYAVYHAAAHKHVPLMEYNPIEAFKNNVLGTRNVATVAKNVGV RKFVMVSTDKAVNPPNVMGASKRVAEMVVQSLNDENCVTDFVAVRFGNVL GSRGSVIPLFKKQIAAGGPVTVTHPDMTRYFMTIPEASRLVLQAGALAKG GEVFVLDMGEPVKIVDLARNLIRLSGKTEDEIPIKFSGIRPGEKMYEELL NENEIHPEQVYEKIYRGKVRDFSKEEVDAIVSDLANDFKKEKIIKIANE >SH0392 capE, capsular polysaccharide synthesis enzyme CapE MFKDKVLLITGGTGSFGNAVMERFLDTDIKEIRVFSRDEKKQDDMRKKYN NPKLKFYIGDVRDSHSVETAMREVDYVFHAAALKQVPSCEFFPMEAVKTN IIGTENVLQNAIRNNVKKVICLSTDKAAYPINAMGISKSMMEKVFVAKSR NVDSEQTLICGTRYGNVMASRGSVIPLFIDKIKAGEPLTVTDPNMTRFLM SLEEAVELVVHAFKHAQTGDIMVQKAPSSKVGDLAEALLQLFEANNEIKI IGTRHGEKQAETLLTREEYAQCEDMGDYFRVPADSRDLNYSNYYEDGSEK ITEAYEYNSDNTNILTVEEIKEKLLSLEYVRTELNNYKKG >SH0393 capF, capsular polysaccharide synthesis enzyme CapF MKIVITGSNGFVGKNLKEDLKATTNNEILEVNRQTSSEDLKKYLLEADSV LHLAGINRPQREEEFKEGNVDFLSEVLEILKENPKKPDVILSSSIQATND NPYGNSKRQGEGVLEQFSKENGNKVLIYRLPNLFGKWCKPNYNSVIATFC YKIARDEEIQVNDENVVLHLNYIDDVIKEFKNAIDGRPNIENGELKVPNV YEVKLGTIAKLLYEFKEIANKKSLPNTENSFEKCLYSTYLSYLPEDKFSY PLKMNVDNRGSFTEIFKTMDRGQVSVNISKPGIVKGNHWHHTKNEKFLVV SGTGVIRFRKIGEDEVIEYHVSGEKLEVVDIPVGYTHNIENLGDTDMVTI MWVNEIFDPNNPDTYFLEV >SH0394 capG, capsular polysaccharide synthesis enzyme CapG MEKLKLMTIVGTRPEIIRLSATIKACDKYFNQVLVHTGQNYDYTLNQVFF EDLELREPDHYLEAVGNHLGETMGNILAKSYEVLAKEQPDALLILGDTNS CLAAVSAKRLKIPVFHMEAGNRCFDQNVPEEINRKIVDHVSDVNLPYTEH SRRYLLDEGFQKQNIFVTGSPMKEVLNEYAYKIDESNILNKLELETQKYI LVSAHREENIDNEKNFLSLMNAINDIAEKYQIPVIYSTHPRSWKKIEERN FKFHPLVRQLKPFGFFDYNALQKNAFVVLSDSGTLSEESSILKFPGVLIR TSTERPEVLDKGTVIVGGISYDNLVQSVELAKSMQENDEPMIDAIDYKDT NVSTKVVKIIQSYKDIINRNTWRK >SH0397 capJ, MDYVGKVGGASSISRQFYEDVKNDENNQWIFLTNKEYVSQKSNIKRILVN NANKTFLHRFYFETFKIPNIINNIKPDLVLSLQNLGVKPKQNQILYIHQA LPFQNKLWELSNNPISLVKMLLMKYKLIKDIKKSNHIIVQTNYMKKLIEK YNNNIIVNLPNFNFASPQTHKDTKDFLYPTNAQKYKGLNYIVDFARILKK NKQNVYINLTLIGNENKYIENIRKIINKEQLAIRFIGRQNSDEMNELYKL NNLLFTSQVESLGLPLIEAAHYGCKIFAYETDVTKEVLKNYKFKVFFNKS NIESKYKEFLSFPPTTIGENINGLNINGILRTNHIIK >SH0398 capK, MNALFLTVGNFRSIHNQGIYQDFIKELSTKCEYVLVVSPVQRREKKSTYI IREGNVVILRVKIPNITKTNKIEKGISTLLIEKLYAKAINKYFNDVKFDT IIYSTPPITFSGLIKKLKKTNHSQTYLMLKDIFPQNAVDLKMFRANGLFD RYFRNKEKNTYKISDFIGVMSPANKNYLLSHNSYISENKVHLFRNSTYDS SKEINENERISILKKYNLSSNKTTFIYGGNIGVPQGTDAIKEVIKRFNEM ENSQLVIVGSGTKFKEIQNYAQNIKDVFVLNQLPKKDYDLLLSVSDIGLV FLDSRFTIPNYPSRLTSYLMLSKPVISMTDENTDIGMEIEKYDCGFSIVN ENIDKFILDSNKLANDIDLRKQMSINAKKMFNDLFRIEENVREMLNFITK KEREE >SH0399 capL, MTTDRIFLSRPHMGGTELDYIHDAFEKNWVAPLGENVTEFENSMKNYTGV KAALALTSGTSAIHLALIESGVKRDDIVFCSSLTFSASANPIIYQGAKPV FIDSEKDSWNMSPIALKKAFEKYAEKGITPKAVIAVNLYGQSAKMDEIKE ICDEYKTTLVEDAAESLGADYKGHKSGTFGKFGIFSFNGNKIITTSGGGM LISNDEDSIAHALFVSTQARDKALHYQHSELGYNYRLSNISAGIGRGQME VLDQRIQRRREIFEKYDEAFGNIDGFDFQPELPDSKSNRWLTALTIDENK TGFSALELIDALQKNNIEARPVWKPMHLQPYFESYDYIMVDGVDNSAHLF DHGVCLPSGSDMTDEQQTRVIEIIKSL >SH1486 ctpA, probable carboxy-terminal processing proteinase ctpA MSHNPEEKQSNLDSNHKNESSSNKRIKFKTWQFILLLLGVVIITAGITVA ATIGISHKISGLTKDERQEIKKIEYAYKTLNNDYYKKQNAGKLSEAAIDG MVKELKDPYSEYMTKDETKSFNEDVSGDFVGIGAEMQKKDKQIMITSPMK DSPAEKAGIQPKDVVTKVDGKSVVGKPLDQVVKLVRGKEGTTVKLTIKRG SQEKEIKIKRGKIHVKSVEYKKKDNIGVFTINKFQDNTAGELKSAIIKAH KDGVRSIVLDLRNNPGGLLDEAVKMANIFIDKDQTVVKLEKGDDTESIKT SNDASNEAKDMKVSILVNEGSASASEVFTGAMRDHKKAKVYGSKTFGKGI VQTTREFKDGSLLKYTQMKWLTPDGHNIHGKGIQPDTKIASPQYQSISVI PTDKSYSVGDNTKYVKSIKIGLDALGYNVNNDSKQFDTQLESAIKKFQSE HELSVNGKFDKKTNEKFTQLLVEKANKEDKVLDELINKLK >SH0426 cudT/betT, choline-glycine betaine transporter MDWPTFIGTVIVLLVAVTPMMVFPKASEKVITDINSAISNSIGSVYLFMG LIILFFVLYIAFGRYGNVTLGKATDRPEFNNFSWASMLFCAGIGSDILYW GVIEWAFYYQVPPNGAKGMSDEALTYATQYGMFHWGPIAWAIYVLPALPI GYLVFVKKQPIYKISQACRPVLKGQTDKFLGKLVDILFIFGLLGGAATSL ALGVPMISAGIEKLTGIDGENMVVRSIILLTITVVFAVSSYSGLKKGIQK LSDVNVWLSFLLLGFVFIVGPTVFIMETTITSFGNMLRDFFHMATWMEPF GGIKGRKETNFPQDWTIFYWSWWLVYAPFIGLFIARISKGRRLKEVILGT IIYGTLGCLLFFGIFGNYAVYLQITGEFNVINFLNSHGTEATIIQVMHQL PFSSLIVVLFLISAFLFLATTFDSGSYILAAASQKKVIGEPLKANRLFWA FALCLLPFSLMLVGGERALEVLKTASILASVPLIVIFIFMMISFIITLNR DRIKLETRADKHKEIERRSLRIVQVKEKSDDDDNL >SH1516 dapA, Dihydrodipicolinate synthase MPHLFEGVGVALATPFTNNEVDYNALEKHVDFLLDNGVKAIIVNGTTAES PTLTEEEKEQVLESVIKQVNHRVTIIAGTGTNNTAKSIQASQRAKALGAD AIMLITPYYNKTNQRGLVKHFETIANEVELPVVLYNVPSRTNMTIEPETV ETLSHNQYIVAIKDATNDFEYYEDVKSRINQEEFALYSGNDDNVVEFYQR GGNGVISVIANAIPKEFQALYDAKQSGQDISNDFEPISKLLDALSVDVNP IPIKALTSHLGFGNYELRLPLLPLEDADAKVLINVFEQFKAGEL >SH0954 ddlA, D-alanine-D-alanine ligase MVKENICIVYGGKSAEHDVSKLTAQNVLNAIDKERYLVDIIYITNDGLWK KKENITEEIKEIESLNMTDIEAGEITILLKESSNGKPYDAIFPLLHGPNG EDGTIQGLFEVLDLPYVGNGVLAASSSMDKLVMKQLFEHRGLPQLPYISF LRSEYEKYEGNIIKLVKDKLTYPVFVKPANLGSSVGISKCNNEDELKSGI EEAFQFDRKLVIEQGINAREVEVAVLGNDYPETTWPGEVIKDVAFYDYKS KYKDGKISLQIPAELDEEVQMTLRNMALEAFKATDCSGLVRADFFVTEDN QIFINETNAMPGFTAFSMYPSLWENMGLSYSDLITKLIDLAKERHEDKKK NKYTID >SH2020 dltB, DltB membrane protein MIPYGTFTFFLVAIIVLLPVIILGFLGKRSYIYNGLSTAIMIVVIFSSDK HNLFGNKYLSIQLISFVIYLIWQVLLIMGYYKSRQKSNTFSKFVIVMILS ILPLAIVKVLQSSWLGGQQIHFHEHKLIEFVGFLGISYVTFKSVQLIMEI RDGSIKEIKVGKLFQFISFFPTVSSGPIDRYKRFVKDDKKVPTSEQYREM VAKAIHMIMLGFLYKYIIAYLINVYAILPLLMNLDGFMHKWLYMYAYSFY LFFDFAGYSLFAVAVSYLYGINTPPNFKQPFKAKNIKDFWNRWHMSLSFW FRDCIYMRTLFYMSRKKTFKSQFAMSNFAFFLNFFIMGVWHGLELFYIVY GIYHGLMFIGYGYYERWRKKHPPRWQNGFTKALSIIITFHFVAFGFLIFS GKLI >SH2018 dltD, poly D-alanine transfer protein MKLKPFLPIIISGILFLAFVLMPASWFTGLVTNKAVANNRISLTDQVLKG TLIQNKLFSSDKYYPIYGSSELNKLDPFNPALALNHRKNTKPIFLIGTGG NTDLINAIELAGQYDQLKGKKMTFIISPQWFSTHGVNDRDFAARTTPNQI NQLFQQKDMPSELKERYAKRLLHFKSASNKEFLKDVVNNHGEVDGNYVSR FKENQLLKIEAIKTYFSLDKSPLSHVKPVTEPNVSWQEMQDKAVTLGEKR SSSNNYGIRNEYWEKLIHKKPMNHRKYEFKMNSPEFNDLSLLVDTMHNAS ADVQYVILPVNGKWYDHLGIERSTREPVYKKIHQTVVAHGGKVYDMSDKD YEKYVLSDVVHVGWKGWAHMNQHIVQHMKDDKNEHNKDHNKQHEHQ >SH1431 ebpS, cell surface elastin binding protein EbpS MSKNNFRDDFEKNRQSINSDDQFEDNTNEFDENSNESNDFDNQSDQQFPP RNAQRRQRRRNQATNKNRKFGNQNSDSNANGSLDDRHDEDSFNELQHNQQ ENHLDNEPIHKDDKLSSEKDFNNDASRRNNRHEASNRKHDKDYDNGSLND DDRHRRNHEEGIDERQDNRNHKDQQNKKSRHGKDAAIAGGAGVAGAAGAK AAKDKRKKDEHHDSKYNEHKDDRDLNNDNQFDQNRKHDKDLHDDHRDAKD NHSKEEPKKGNKGKKAAVGAGAAGAAGAAGVAAAKHKKDHKNNNHKDNHS HNRDHQDDHRNHKHEDGNDGFQAHNGKKKRGLAGILLPLIALLLILAALA IFIGMYLNNDKKDSNQADNKTEQTANKDNNKDSKDKASNDSDKDKASSDK DKDKATNDDDSNDKATTDNDSSNNSSDDNSSSSDNSTSSNSSDNSSSSDN NGNNSNSDNNNGNSQATSNNSSQSNSNNNQSNSSNSGQQTHVVSGNENLY RIAIQYYGEGTVENVNKLKQANGLSSNNISNGQKLIIPQ >SH2512 gcaD, MQRNAVILAAGKGTRMKSNKYKVLHKVAGKSMVEHVLTNVKNAGVNQIVT IVGHGAEDVKETLGNQSLYSYQEEQLGTAHAVKMANEHLKEVEGTTLVVC GDTPLITAHTLQKLIEHHESTHAQATVLSATAQIPFGYGRIVRDEQRRLQ RIVEEKDASEAQKALTEISSGIFAFDNRVLFSKLEEVKNDNAQGEYYLPD VISLILAENGVAEVYHTDDFNEIMGVNDRVMLSNAEKALQQRINIEHMRN GVTIIDPTTTFIGPDVKIGMDTIIEPGVRINGETVIGEEAVIGQYSEINN SHIGSQVDIKQSVINDSIVGDKTKVGPFAQLRPGSNLGSDVKVGNFVEVK KADLKDGAKVSHLSYIGDAEIGERTNIGCGSITVNYDGVNKFKTVVGKDA FIGCNTNLVAPVTVGDGVLIAAGSTITDNVPNESLALARARQITKEGYLK K >SH2674 gidB, glucose inhibited division protein B MNGIEWLAKELSEHGIELSDKQKEQFQTYYRLLVEWNEKMNLTSITDEHE VYLKHFYDSITPSFYYDFNQPLTICDVGAGAGFPSIPLKVVYPELKVTIV DSLNKRIQFLNHLAAELGLTQVSFVHDRAETFGKGVNRETYDVVTARAVA RLTVLSELCLPLVKKGGQFIALKSSKGEEELEEAQFGISILGGVFSDSYT FDLPEDAGERQMIIIDKRRQTSKKYPRKPGTPNKSPLLEN >SH0880 glmS, glucosamine-fructose-6-phosphateaminotransferase MCGIVGYIGYDNAKELLLSGLEKLEYRGYDSAGIAVANDNGTTVFKEKGR IAELRKVADNNDTDGHVGIGHTRWATHGVPSTVNSHPHQSNNERFTLVHN GVIENYEELKSEYLSDVTFQSETDTEVIVQLVEHFSNKGLETEEAFSKVV SLLHGSYALGLLDNQDSDTIYVAKNKSPLLVGVGEGFNVIASDALAMIKV TNEYKEIHDHEIVIVKKDSVTIKDLDGNVQDRDTYTAQIDASDAEKGIYD HYMLKEINEQPAVMRRIIQEYEDEKGDLKIDPEIVKDVAAADRIYIIAAG TSYHAGLVGKEYLEKWAGVPTEVHVASEFVYNMPLLSEKPLFIYISQSGE TADSRAVLVETNKLGYKSLTVTNVAGSTLSREADHTLLLHAGPEIAVAST KAYTAQIAVLSILSQVVAKAHGRDNDIDLLRELAKVTTAIETIVDDTPVM EQIAKDFLETTRNAFFIGRTMDYNVSLEGSLKLKEISYIQAEGFAGGELK HGTIALIEDGTPVIALSTQEKVNLSIRGNVKEVVARGAKPCIISMEGLEK EGDTYVIPHVHELLTPLVSVVTLQLIAYYAALHRGLDVDKPRNLAKSVTV E >SH0579 gtaB, UTP-glucose-1-phosphate uridyltransferase MKQIKKAIIPAAGLGTRFLPATKAMPKEMLPILDKPTIQYIVEEASRAGI EDIIIVTGKHKRAIEDHFDNQKELEMVLEEKGKDDLLEKVQYSTDLANIF YVRQKEQKGLGHAIHTARQFIGNEPFAVLLGDDIVESETPAIKQLMNVYE ETGHSVIGVQEVPESVTHRYGIIDPLEKEGRRYEVKQFVEKPKQGTAPSN LAIMGRYILTPEIFDYLETQKEGAGNEIQLTDAIERMNSDIPVYAYDFDG DRYDVGEKLGFVKTTIEYALKDPKMKDELIKFIKELGF >SH1332 lepA, GTP-binding protein MDMQERYNRRENIRNFSIIAHIDHGKSTLADRILENTKSVETREMQDQLL DSMDLERERGITIKLNAVRLKYEANDGQTYTFHLIDTPGHVDFSYEVSRS LAACEGAILVVDAAQGIEAQTLANVYLALDNDLELLPVVNKIDLPAAEPE RVKQELEDVIGLNQDDVVLASAKSNIGIEDILEKIVEVVPPPEGDPSEPL KALIFDSEYDPYRGVISSIRVMEGVVKAGDKIKMMATGKEFEVSEVGINT PKQLPIEELTVGDVGYIIASIKNVDDSRVGDTITHANRPAEAPLKGYKKM NPMVYCGLFPIENKDYNDLREALEKLQLNDASLEFEPESSQALGFGFRTG FLGMLHMEIIQERIEREFGIELIATAPSVIYQCIMKDGSEVTVDNPAQMP ERDKIDSIYEPYVKATMMVPNDYVGAVMELCQRKRGQFINMDYLDDIRVN IVYEIPLSEVVFDFFDQLKSNTKGYASFDYEFIENKESNLVKMDILLNGD KVDALSFIVHKDFAYERGKALVEKLKTLIPRQQFEVPVQAAIGQKIVART NIKSMGKNVLSKCYGGDISRKRKLLEKQKAGKAKMKAVGSVEIPQDAFLA VLKMDDE >SH2128 lgt, prolipoprotein diacylglyceryl transferase MLFNLNYIDPTAFSIGPLSIKWYGIIIAVGILIGYFIAQESLKYVGLHKD RLVDVIFYSAIFGFIAARIYFVIFQWPYYAQNPIEIPMIWHGGIAIHGGL LGGFITGIIVCKIKNLNPFQIGDIVAPSIILAQGIGRWGNFMNHEAHGGP VSRTFLENLHIPEFIIRNMYIEGVYYHPTFLYESIWDILGFIILITIRKH LRVGETFTLYLIWYSIGRFFVEGLRTDSLMLTSHIRVAQLVSVILIIIGL VILIYRRIKYQPSLYKEAGPLTWNSSKAKVKS >SH2144 llm, lipophilic protein affecting bacterial lysis rate and methicillin resistance level protein MYTLLLIAVTLVISLILTPMIIKVSIKFDLVDRPNFRKVHTKPVSVLGGT VILLSFLIGIWLGHPIEREVKPLVMGAIVMYLVGLIDDIYDLKPILKLIG QIVAASIVAFYGITIDFISFPMGPTIHFGILSIPITIIWIVAITNAINLI DGLDGLASGVSAIGLITIAFIAILQANVFIIMICSVLIGSLLGFLCFNFH PAKIFLGDSGALLIGFIIGFLSLLGFKNITFISLFFPIVILAVPFIDTLF AMIRRMRNGQHIMQADKSHLHHKLLALGYSHRQTVLLIYSIAILFSLSSI ILYLSQPLGVLLMFILIVITIELIVEFTGLIDDSYRPILNLITKKNEQHH GDNGVDQHDKK >SH0610 lrgB, holin-like protein MVDHLGITTPYFGILVSLIPFVIAQYFYKKTNGFFLLAPLFVAMVAGIVF LKVTGISYENYKIGGDIINFFLEPATISFAIPLYKKRDVLKKYWLQIFGG IAIGTLIALILIYLVAIVFQLGDQIGASMLPQAATTAIALPVSQGIGGVK ELTSLAVILNAVVISALGTKIVKWFKISNPIARGLALGTSGHTLGVAAAK ELGETEESMGSIAVVIVGVIIVAIVPPLASILF >SH1718 lsp, Lipoprotein signal peptidase (Prolipoprotein signal peptidase) MKKKYYITISLIVAIAILIIDQVTKRIIATTMNIGDSYEVIPNFLNITSH RNNGAAWGILSGKMGFFYIITIVILIVLVLFYIKEAKYNLFMQVAISLLF AGALGNFIDRLVNGEVVDFVDTNIFGYDFPIFNVADSSLTIGVLFIIIAL LKDANSKE >SH1289 lytH, N-acetylmuramoyl-L-alanine amidase MNHSDQGSNRITVSENAELRTGPNAAYPVIYQVEKGDTFTRLSKSGKWIE VESRDGSEKSWIAGWHTSLNIEAGANKKVNPLKNKVIVLDPGHGGNDQGA SSNTSKKSLEKNYTLKTAKELRRALEKAGATVKLTRSDDTYVSLDDRKLN GDAYISIHNDSLDSPNANGATVYWYKNNQEALAETLNTNIQKKAMLFNRG TRQENFQVLRQTNKPAVLLELGYISNPTDEVMIRNQIHRQVVEEAVVDGL KQYFAS >SH0091 mecA, penicillin binding protein 2 prime MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSS YISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYK IKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSE RGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQ MDQNWVQDDTFVPLKTVKKMDEYLRDFAKKFHLTTNETESRNYPLGKATS HLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAI HPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTS PGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVN GNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYN AQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLL KDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISG KVYDELYENGNKKYDIDE >SH1133 menC, O-succinylbenzoic acid (OSB) synthetase MLIKAVNLYLYNQEFVNPIVTPKVKMTHRKALIVEILSEDDQSFFGECNA FETNWYNEETIETVQEILSQWSESIVKNSFHKYEDWKPYLDILDNYPAAR STLVMAIYQMYHDLPKFKVAYGATISGISAQQLEYLKQTQPKRIKLKWTG QLNDDISLLDDILPYDFELALDANESLDVSDFQKLESINDQNILYVEEPF KSLSSILHIDHTQYPAIALDEKATDINSIISIVNQFPVKVVVVKPFRVGG LDRVQSLIRELKSIDIKVVIGGMYEYGLSRYFTALLAREGDYPGDVTPDG YYFTDDFTQGVGKLKEGMISFHPPQIDKSKLLKLY >SH0924 mnaA, UDP-GlcNAc 2-epimerase MKKIMTVFGTRPEAIKMAPLVKALEYDAELEPMIVVTAQHREMLDSVLHT FNIKPHYDLNIMEEGQTLSDITSRAMTKLEDVIKKERPDMVLVHGDTTTT FSGALAAFYNKVAIGHVEAGLRTRHKYAPFPEEVNRQMVSNLADLHFAPT KGAANNLLQENKSPDSIIITGNTAIDTLELTIQKEYTSDIIRKHQGKRII LLTVHRRENVGQPMINIYKAMRKIVDEYEDIVIVSPLHLNPKVRELAYEY LGEHERIELIEPLDVVDFHNFANKAYLILTDSGGIQEEAPSLNKPVLVLR DVTERPEGVTAGTLKVVGTDFDNVFKSTTEILENQMIYDQMALTQNPYGD GNASLRICESIKYYFGLTSKMPKPFNS >SH1733 mraY, phospho-N-muramic acid-pentapeptide translocase MLFILAVIALLITFILVPILIPTLKRMKFGQSIREEGPQSHMKKTGTPTM GGLTFLISIIITSIIAIFFVDNSNPIILLLFVTIGFGLIGFIDDYIIVVK KNNQGLTSKQKFLAQIAIAVVFFLLSDVFHLVEFSTNLNIPFTNISIPLS FAYVIFIVFWQVGFSNAVNLTDGLDGLATGLSIIGFTMYAIMSFVLDSPA IGAFCIIMIFALLGFLPYNLNPAKVFMGDTGSLALGGIFATISIMLNQEL SLLLIGLVFVIETASVMLQVASYKLTKKRIFKMSPIHHHFELSGWGEWKV VTVFWTAGLISGLIGLWIGVH >SH1560 mscL, large-conductance mechanosensitive channel MLKEFKEFALKGNVLDLAIAVVMGAAFNKIVTSLVTYIIMPLIGKIFGSV DFAKDWEFWGIKYGLFIQSIIDFIIVAIALFIFVKIANTLVKKEEPEEEI EENTVLLTEIRDLLRAK >SH0935 murA, UDP-N-acetylglucosamine 1-carboxyvinyl transferase 1 MDKIVIKGGNRLTGEVKVEGAKNAVLPVLTASLLASEGQSKLVNVPDLSD VVTINNVLSTLNANVEYNKEEGAVLVDASTTLKEEAPYEYVSKMRASILV MGPLLARLGHAIVALPGGCAIGARPIEQHIKGFEALGAEIHLENGNIYAS TKDGLKGTDIHLDFPSVGATQNIIMAASLAKGKTVIENVAKEPEIVDLAN YINEMGGKVTGAGTDTITIHGVEKLRGVEHSIIPDRIEAGTLIIAAAITR GDVFVRDAVKEHMTSLIYKLEEMGVNLDFQEDGVRVTAEDELKPVDVKTL PHPGFPTDMQSQMIALLLTAEGHKVITETVFENRFMHVAEFRRMNANITV EGRSAKIQGKSQLQGAQVKATDLRAAAALILAGLVAEGTTQVTELKHLDR GYVNFHEKLKSLGANIERVNY >SH2153 murB, UDP-N-acetylmuramate dehydrogenase MLKQEDILQDLKSLIPEDIIKVNEPLKRYTYTETGGNADFYLSPTKNEDV QAIVRYAKEKDIPVTYLGNGSNIIIREGGIRGIVISLLSLNHINVSDDAI IAGSGSAIIDVSRAARDHVLTGLEFACGIPGSVGGAVYMNAGAYGGEIKD CIDYALCVNEEGDLIQFTNKELELDYRNSIVQKQHLVVLEAAFTLEPGKL DEIQAKMDDLTERRESKQPLEYPSCGSVFQRPPGHFAGKLIQDSDLQGYR VGGVEVSKKHAGFMVNVDNGTATDYEDLIHHVQKVVKEKFDVELHREVRI IGEHPKE >SH1182 murC, UDP-N-Aacerylmuramate-alanine ligase MTHYHFVGIKGAGMSSLAQIMHDLGHEVQGSDIEKYVFTEVALKNKGIKI LPFNADNIKEGMVVIQGNAFPDTHEEIVKAHDLKLDVIRYHDFLGHVIDQ YTSVAVTGAHGKTSTTGLLSHVMNGDKKTSFLIGDGTGMGLPASDYFAFE ACEYRRHFLSYHPDYAIMTNIDFDHPDYFKDIDDVASAFQSMAHNVKKAI IAWGDDDHLRQLKADVPIYYYGLNKNDDIYADNIQITDKGTQFDVYVNGE YYDQFLSPQYGDHNIQNALAVIAISYLEKMDVNNIKEALETFGGVKRRFN ETNVANQVLVDDYAHHPREISATIETARKKYPNKDIVAVFQPHTFSRTQA FLDEFATSLSKADHVYLCEIFGSIRENTGDLTIQDLINRIDGSALIEENN IDVLDQFDNAVILFMGAGDIQKLQRAYEEHVGMTNEF >SH1732 murD, UDP-N-acetylmuramoylalanine-D-glutamate ligase MLNYTGLENKDVLVVGLAKSGYEAAKLLIKLGANVTVNDGKDLSQDPHAK DLEALGVKIVDGGHPLSLLDNEPIIVKNPGIPYTVSIIQEAYQRHLKILT EVELSYLISEAPIIAITGTNGKTTTSSLIGDMFKKSRLTGRLSGNIGYVA SKVAQETSPNEYLITELSSFQLLGVEQYRPHIAIITNIYSAHLDYHETLE NYQNAKKQIYKNQTENDYLICNYHQRHLIESENLKAKTLYFSTQQEVDGI YIKDGFIVYQGIRIINIDDLVLPGEHNLENILAAVLASILAGVPIKAIID SLTTFSGIDHRLQYIGTNRTNKYYNDSKATNTLATQFALNSFKQPIVWLC GGLDRGNDFDELIPYMKNVRVMVVFGQTQEKFAKLGNSQGKLVVKATDIE DAVKKVQDVVEPNDVVLLSPACASWDQYKTFEERGERFIESFRAHLPSY >SH1941 murE, UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase MNANELFEKIRVKQVIGTLDINVTDITTDSRTASEGSIFVASKGYTVDSH KFCQNVVDQGAKVIVVNHQQDINGDVTQVIVPDTLRVASLLAHTLYDFPS HQLTTIGVTGTNGKTSIATMIHLIYRGLGKGSAYLGTNGFQINEHKTRGA NTTPETVSLTKKIKQAVDENAEAMTMEVSSHGLSLGRLRGVEFDVAIFSN LTQDHLDFHGTMEAYGHAKSLLFSQLGEDLSKEKYAVLNNDDDFSKYLAS VTPYEIFTYGIDHDAQFMAKNIQESLQGVHFDFDTPIGTYSVKTPYVGKF NISNIMAAMIAVWSKGTSMEDIVRVVENLEPVEGRLEVLDPSLPIDLIID YAHTADGMNKLIDAVKPFVKQKLIFLIGMAGERDLTKTPEMGAVACRADY VIFTPDNPANDDPKMLTAELAKGATHNHYVEFDDRAEGIKHAIDIAEPGD TVVLASKGREPYQIMPGHIKVPHRDDLIGLEAAYKKFGGGPSEH >SH0955 murF, UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate-D-alanyl-D-alanyl ligase MIEVTLQQIQEWIPCDIDSQYLRQTIKGVTIDSRAIKTNMLFIPFKGENV DGHCFVSQALKDGAGASFYEKGHDIDDNVKGPIIWVDDTLIALQQLAKAY LKHVNPKVIGVTGSNGKTTTKDMIESVLHTEFKVKKTQGNYNNEIGLPLT ILELDLDTEISILEMGMSGFHEIELLSNIAEPDIAVITNIGESHMQDLGS REGIAKAKSEITIGLKKEGTFIYDGDEPLLEPHVKKIKHAKCLSVGLKQD NALVCEVEHSENDGIAFSINGNEHYKLPILGIHNMKNAAIAIAIGHELGL KYETIQHNINHVQLTGMRMERHITDDDITIINDAYNASPTSMKAAIDTLS QMEGRKIIVLADSLELGENSRSMHEEVGAYLEGKNIHTLLTYGKDAKYIS DIGGQFVDHVEYFIDKQQLTQYLINNLVANDKVLVKGSRGNKLEEVVNKL I >SH1488 murG, undecaprenyl-PP-MurNAc-pentapeptide-UDPGlcNAc GlcNAc transferase MSKIAFTGGGTVGHVSVNLSLIPTATDKGHDAFYIGSKTGIEREMIESQL PNIEYYPISSGKLRRYLSVDNAKDVFKVLKGVIDARKVLKREKPDLLFSK GGFVSVPVVIAARSLNIPTIIHESDLTPGLANKISLKFAKKIYTTFEDTL KYLPKDKADFVGATIRQDLKEGNQSRGYQLTGFDASKKVLLVMGGSLGSK KLNQAIRENLEALLQDYQIIHLTGHGLVDSSIDAKGYVQYEFVKEELTDL LAITDTVVSRAGSNAIYEFLTLRIPMLLIPLGLDQSRGDQIDNAENFESK GYGRTIPEDQLTQVKLLEQLKEIENDRESIIKQMETYRESYTKEDLFNKI LKDAL >SH1811 murI, Glutamate racemase MNKPIGVIDSGVGGLTVAKEIMRQLPNETIYYLGDIARCPYGPRPGDEVK QFTTQLANKLMQFDIKMLVIACNTATAVALEHLQQMLPIPVIGVIEPGSR TAIMTTKNQNVLILGTEGTIKSEAYRHHIKHINPNVHVYGVACPGFVPLV EQMRYDDPTITSIVIHQTLKQWRNTDADTIILGCTHYPLLYKPINDYFGG EKKVISSGLETAREVSALLTFSNEHASYTQHPEHRFFATGDTVHIKNIIL QWLKLDVEVERISVDE >SH0911 murZ, UDP-N-acetylglucosamine 1-carboxylvinyl transferase 2 MTQEVIKIRGGQTLKGDVTISGAKNSAVAIIPATLLAQGQVKLDGLPQIS DVETLVSLLEDLNIKAHLNGKTLEVDTSEIENAPLPNNKVESLRASYYMM GAMLGRFKKCVIGLPGGCPLGPRPIDQHIKGFKALGAEIDESNDTSMKIE AKELHGANIFLDMVSVGATINIMLAAVHATGQTVIENAAKEPEVVDVANF LNSLGADIKGAGTSTLKINGVDSLHGSEYQIIPDRIEAGTYMCIAAAVGE EITINNIVPKHVEALTVKLKELGVDIQVDGDAEKAIIKRKSSYKNVDIKT LVYPGFATDLQQPITPLLFMADGPSFVTETIYPARFRHVDELKNMGANIE ADMETGTATIKPSSLNGAEVYASDLRAGACLIIAGLLAEGVTTIYNVRHI YRGYTDIVKHLKELGANIWTEEV >SH0282 nanA, N-acetylneuraminate lyase subunit MEDKLKGLYAALLVPFDEHGQVKEEGLKQIAKNAIETEKLDGLYVNGSSG ENFLISKEQKKQIFRVVKETVGDDVNLIAQIGSLDLNEAIELGKYATELG YDALSAVTPFYYPFSFEEIKQYYFDIIEATQNNMIIYAIPDLTGVNISIE QFGELFNHEKVVGVKYTAPNFFLLERIRKAFPNKLILSGFDEMLVQATIS GVDGAIGSTYNVNGRRARQIFDLAREGKIAEAYQIQHDTNDIIETVLSMG IYPTLKEILKSRGIDGGLPKRPFRPFDESHRDALDTLIKKYDL >SH2171 opuBC, MSELFSTLNDRKGEVLTTILEHIQISFIALLIAILIAVPLGIALTKTKRL SEVVMNIAAILQTIPSLALLGLMIPIFGIGRVPAIIALVVYALLPILRNT YTGIKEVDPSLIEAAKGIGMKPMRRLTKVELPIAMPVMMAGIRTAMVLII GTATLAALIGAGGLGDLILLGIDRNNTSLILIGAIPAALLAIMFDLILRY MEKLSYKKLLITVGAMILIILLVIVVPLFGKKGDTITLAGKLGSEPSIIT NMYKILIEDETDDTVDVKDGMGKTSFLFNALKSDDIDGYLEFTGTVLGEL TKEDLKSKKEDAVYQQAKQSLEKKYDMTMLKPMKYNNTYALAVKRDFAKE NNIKTIGDLQKVEDKIKPGFTMEFNDRSDGYKAVAKAYGLNLSNVKKMEP KLRYTAVEKGDINLIDAYSTDAELKQYNMVVLKDDKHVFPPYQGAPMFKE KFLKQHPEIKKPLNKLEGKISDEEMQEMNYKVTVKNEDPYNVAKHYLEKE GLVK >SH0608 opuCC, glycine betaine/carnitine/choline ABC transporter opuCC MKKLKLTFILLAMSLIVLSGCSLPGLGDGDGKDSVKITATETSETKIMAN IEKLMIEHYTNGKIKPTIVGNLGSSIIQHNALQRGDVNMSAVRYTGTELT SVLDAPPTKDTKKAMSESQRLFKEKYNQKYYDSFGFENTYAFMVTKEVAE KYHLEKVSDLKKYKDELRLGMDTQWMNRAGDGYPAFQKEYGFKFASARPM QIGLVYDALKNKKLDVAVGYSTDGRIAAYDLKILKDDRKFFPPYDGSPLA TEKLIKDHPEIDKALKKLQGQISTKEMQKLNYEADGKGKEPAVIAEEYLK KHNYFEDDSKKGGQK >SH0853 opuD, MRKKSISFVFWIALAICTLFVLYGAFMPKQLETGTQNITSFIAKNFSWYY LLLVLLIFFVCVYLLFSRYASITLGEEGEDPEFSLPSWFAMLFSAGMGIG LVFWTTAEPISHAFTLTPIHKAGTQSAINDAFQFSFFHWGLHAWAVYGIV ALVFAYFSFHKGYPGLVSATLVPIFGEKSMKGPIGGAIDVLAVIATVTGV AATLGFGALQINEGLNFLFNVPNNFGTQVILIIIATILFTWSAWSGIDKG IKTLSNVNMFLAFIVLIGLFIVGPTLYILNTFTNGLGNYIFNFFSMSLRI PMNGGEKFQWLQNWTIFYWAWWVSWAPFVGIFIARVSRGRTIKEFILGVL FVPALVCFFFFAVFGASAVYLQDKGIANIAKEATETATFATLEHYPLGFI LSIITLVVIMIFFVTSADSATYVLGMLSSKGDINPASFVKVSWGIILALF AMIMIYTGGTQAIQNLLIIAALPFSIVIILMIWSLFKSLSIDHPRTSNKF PNILQYKSSKQKELKK >SH1559 opuD, glycine betaine transporter MNSSSEETKQNKKFSSVFIYSAIVVAIVVSIGAFLPEQFGKITGDISSWI TEKLGWYYMILTTVIVFFCIFLIFSPIGKLKLGKPNDKPEFNTVSWFAML FSAGMGIGLVFYGAAEPMADFASPPNADPKTTEAYTEALRSTFFHWGFHA WAVYGVVALALAYAQFRKNEPGLISRTLRPILGDKVEGPIGTIIDVLSVF ATVVGVAVSLGMGALQINGGLHYLFGVPNNVWVQSIIIVVVTILFLASAW SGLSKGIQYLSNLNIGLGTVLMIIALIIGPTVLILNMFTSSTGSLLNSFL FNSFDTAALNGQKREWMSSWTLYYWGWWLSWSPFVGVFIARVSKGRSIRE FISGVLLVPAIVSFLWFSVFGVLGIETGKKHPELFKMTPETQLFGVFHHV PLGMALSLIALVLIASFFITSADSATFVLGMQTTFGSLEPSSAVKVTWGV SQSLIAFILLLAGGGNGADALNAIQSAAIISAFPFSFVVIMMMISFYKDA NQERKFLGLTLQPNKHRLQDYVKYQQQDYESDILEKRESRRNAEK >SH1462 pbp2, penicillin-binding protein 2 MTENKGSSQPKNGKNGKSKAKKNKNVKRTIIKIIGFLLIAFIVLVLLGIL LFAYYAWKAPAFTESKLQDPKPAEIYDRNGDLVKKLDNGARREHVELKDV PKNMRNAVLATEDNRFYDHGAIDYKRLFGAIGKNLTGGFGSQGASTLTQQ VVKRAFLSEEKSIGRKAQEAYLSYRLEQEYSKDEIFQMYLNKIYYSDGVY GVKAAAKYYFNKDLKDLNLAEEAYLAGLPQVPNLYNIYDNPKQAENRKNT VLYLMHYHNRISDKEYNAAKKINLKANLVDRTAKERQIGTDNSDSEYDSY VNFVKSELMNNKEFKNKNLSDVLQSGIKIYTNMDKDVQKTLQDRIDNGNY YKNEDQRVGSTILDSKTGGLVAISGGRNFKDVVDNNAATDAHLTGSSLKP FLAYGPAIENMQWATNRAIQDESSYSIDGGTFRNYDGNGHGTVTAYDALR QSFNIPALKTWQQVNSQAGDNAVKKFASKVGLDYQSDIGPSDVLGGGASE FSPTQLASAFAAIANGGTYNNAHSIQKVVTADDDTIEFDHTSHKAMKDYT SYMLAEMLTGTFKAYGSAYGHGVSGVTMGAKTGTSTYGTEINQQYNLPDN AAKDVWINGFTPKYTMSIWMGFSEIKEGGVNSFLGHSEQEYPQYLYEDVM SDITSSDDGDFKKPDSVNGSSADNLSVSGHPDNNTTNREVNGSSGSSSSN SSNSSNNSSNSNTSNTNNSGNTNSGTTNNNSTTQGTNTVGSTLSNIFNLN SIFDFKKSS >SH1364 pbp3, penicillin-binding protein 3 MLKRLKEKSNDEKIKHTMNKRISFVFGAIVVIFGIIVLRLGYLQIAQGSQ YSQLVKNDENITVNESVPRGRILDRNGKVLVDNASKLTITYTRSRKTSQK DMLDTAKKLSSLITMKTDKITERDKQDFWIQKHQDEVDKLMKKETSMLNE GSITQDQYDKQLYKKVGDKQINSLSKKDLRVLAIYREMSAGSTMNPQTIK NEDVSEKEYAAVSQQLDSLPGVNTTMDWDRRYPYGDTLRSIFGSVSTSSE GIPKELTEQYLAKGYSRNDRVGKSYLEYQYEDILRGKKKEMKYTTDKSGK VINSEVINPGSRGDDLQLTIDIDLQKKVESLLENQIKTLRSQGAKDMDNA LIVVQNPKNGDILAMAGKQIDKNGKLTDYDLGNFTGQFAVGSSVKGGTLL AGYQNNAIKVGEEMIDEPLHFKGGLTKRSYFNKNDKVRINDKEALMHSSN VYMFKTALKLAGDPYYSGMGLPTDISEAGQKLRKGLNQVGLGVKTGIDLP NETIGQIEPLTNNSGNYLDLSIGQYDTYSPIQLSQYVSTIANDGYRIQPH IGLAIHDATNSDDIGPVKQKIKGNVLNKVNNSEDEIKEVQKGFEMAFNEK DGTGYSSFHKTKVPSAGKTGTAEVFQDGESRVNSTYIGYAPINNPKLSFS IVYTNQPVPPPWLNGGDLGRDVINYYFDDKK >SH2254 pbp4, penicillin binding protein 4 MKRSLIITFALLLTIVIIAPNSYASEYEPTPTEIARQYGYPNVTDAYQPE GSINVSQTGQILYDYQSNQKWYPASMTKLMTMYLTLEAVNKGELSLNDKV HITDKHYRMSTLPELSNTKLYAGETYTISELLQITVSNSSNAAALILADE VSGNVNDFTDLMNKKAKALGMSNTHFVNPTGAENKQLKEFAPSKYKNQDN TTSTAKDFAILDHHVIKETPKILHFTKQLAPTQHGVTYYTFNHSLEGAKM SLLGTDGLKTGSSDVADYNHTITTKRNNFRINQVIMGAGDYVNLGGEKQR NMMGNAMMNRSFDQYSYKKVLSKGTHKINGKKYYVKDNLYDVVPKGMNKK DYKFIVKDGSIHLDYNRQFLTKDDGPPKVEVTKPLLHKANTIAQTTWKEH PVVTFVALALLAIAFILMVRSIIHLLFKRK >SH1734 pbpA, penicillin-binding protein 1 MAKRKIKIRKNKLGAVLLVGIFRLLFFILVLRYSYIMITGHSDGQDLVMR ANEKYLVQNNEQAERGKIYDRNGKILAEDVERYKVVAVVDKSAGKSGDKP RYVEDKKKTAKELSKIIDMKPEEIEKQLNQKKAFQVEFGQKGTNLTYQDK QKLEKMDLPGITLYPETERFYPNGNFASHLIGMAQKNPDTGELKGALGVE KIFDSYLSGTKGALSYIQDIWGYIAPNTKNEKSPKRGDDVHLTIDSNIQV FVEEALDDMVKRYQPKDLFAVVMDAKTGEILAFSQRPTFNPETGEDFGKK WANDLYQNTYEPGSTFKSFGLAAAIQEGKFNPKKKCESGHRDIMGSRISD WNKTGWGEIPMSLGFTYSSNTLMMHLQDLVGADKMKSWYERFGFSKPTGG LFDGEAEGNIAWSNELQQKTSAFGQSTTVTPVQMIQAQSAFFNKGNMLKP WFVDSIKNPISKKTFYQGEKEIAGKPITASTASKVETELDKVVNSKKSHA MNYRVDGYDIEGKTGTAQVADEKSGGYVKGENPYFVSFIGDAPKKNPKVI VYAGMSLAQKNDQEAYEMGVSKAFKPIMENTLKYLNVGSKKDETKSAQYS KVPNVTGQSTDKAKESLKSEDLQATVIGNGDNVKSQSIKANKKLLPNSKV LLLTDGDITMPNMKGWTKDDVLAFQELTGINVTTKGSGYVTKQSVNNGTT LKDNSKVEIELSPEDPDDTSTNTNDNETASNDSSNKDKASSSSDDKEKDN KNDTSSSSEQEQQTNNSQDSNE >SH0533 pgsA, poly-gamma-glutamate synthesis protein PgsA MKKKKRLSASEWLLKQSKRHKRFNFSYTLIVLIVALVLLVFAIRAVKVEP VEAMPSSGNDYIRSTYLGNITLNKHFRQMDLNDVFKGLKQPLQQSDFSTA SLLVSHFSNDPKTNIKKNIENIMFLKKENVKSVNLINNTIDNVQAQDLSK QVEAQTDYNFMTGNGSNPINSKTVQQTVKGKKIANVSFTDVGSNYEDPLK NTTSISLDPKIFVPLIKNLKENNDLVVVNVDWGITNERSVTDRQKEYAHA LVKSGADVIIGHNSVVQKVEKYKNASIFYSLGILTSDSFLSKNQKGMVVQ HDWNGQHNKFSITPVRGADGKITKDNMNKMEAQRYYNNINDKSIHLKEEN GGYTFEY >SH1191 sgtA, MLTNINRDTKFNSFEKFYKKTKHAIVGLFSVGLFICLIGFIGTVIYFNHL THESSKISDRELKQKVLHFAGDDLINHENSDVLSEYDKSENSLIVGPKHV NPNVIKALTSSEDTMFYKHKGILPKALVRAMIQDVFNLDQSTGGSTITQQ LVKNQVLSSKKTYSRKANELILAMRLENLLSKNEIIYTYLNIVPFGRDYE GNNITGIASASYSLFGIPPKDLNIAQSAYLIGLLQSPYMYTPYEENGELK TYKEVKISVDRQHYVLKRMLVEGVIDKEEYRHAKRYHIYDHLLTKPQLNN NQSA >SH1086 sgtB, monofunctional glycosyltransferase MKRSQRMNNSPERHSQYRNEPHYNTYYQPVGKPPKKKKNKRIFLRLFIIF VFIYALFIGLMYYLSSRANVDDLKTIENKSSYVSADNMPDYVKGAFISME DERFYKHHGFDVKGTTRALFSTIGDRDVQGGSTITQQTVKNYYYDNERSF TRKLKELFVAHKVEQQYSKNEILSFYLNNIYYGSDQYTIESAANYYFGTT VNKNSDSMSQITVLQSAILASKVNAPSVYDISNMSDNFKNRIKTNLEKMK QQEYISDSQYQEALSQLNNY >SH2513 spoVG, MKVTDVRLRKIQTDGRMKALVSITLDEAFVIHDLRVIEGNSGLFVAMPSK RTPDGEFRDIAHPINSDMRQEIQDAVMKVYDETDEVIPDKNASSEDSDEA >SH0543 srtA, sortase A MKNWINRLMTILGVILILVAVYLFAKPHIDNYLHEKDNDNKIEQYDKQDK SSNKQTPTIPKDKTKMAGYISVPDAEIKEPVYPGPATPEQLNRGVSFAEK DESLSDQNISIAGHTFTDRPHYQFTNLKAAKKGSKVYFKIGNETREYKMT SIRDVNPDEVEVLDEHKGEKNQLTLITCDDYNEQTGVWEKRKIFVAKQVN >SH2260 tagA, teichoic acid biosynthesis protein MHDQKETTATKVDILGVQFNNVTMLDMIEHVKTFFTQETEDNLFIVTANP EIVDYASEHSTYKQLINSADFVVPDGTGVIKASNRLGTPLKRRVPGIELM EHCLKIAHTNYQKVYLLGAKNEVVTLAHKNLQHKYPQAQFDYHHGYIDLN DETVIKRIKRFDPDYIFVGMGFPKQEEWIQKHRHTFKRTVMMGVGGSFEI YSGTKKRAPKLFIKLNIEWVYRLLIDWKRIGRMRSIPKFMFKVFKVQRKM KKKK >SH2257 tagB, teichoic acid biosynthesis protein B MRLIIKKVYMLMITLLNFIYKRRQVDKKQITVLMTFPEDVMPIINELDNK GYKITVIAKFEEQYRLEHLNNITFIPAGNKYIVKHIKALSSSKVILIDTY YLMLGGYTKKKAQTIIQTWHASGALKNFGLTDHQVDLNNVTMVRQYQRVY QATDYYIIGGKEMGTCFKESFEATEDQLLPLGLPRLSQYLKFNLKAEQER LKKHYNIHKKLVVYVPTYREGSENNRQIDVARFEEALPEYTLINQLHPSI SKSQSIATTQELMIMADVIISDYSSLPIEASLLDKPTLFYVYDEHKYDKI RGLNQFYKAIPQQYKVTTEEELILKIRNDIALFKPLFKNWHKYNREDSVR RVTEFIEKMVKR >SH2255 tagD, teichoic acid biosynthesis protein D MRRVITYGTYDLLHYGHIELLRRAREMGDYLIVALSSDEFNQIKNKKSYY DYEQRKMMLESIRYVDLVIPENDWGQKEIDVDRFEVDVFVMGHDWEGEFD FLKDKCEVVYLKRTEGISTTKIKQELYGKDAK >SH2250 tagF, glycosyl/glycerophosphate transferases involved in teichoic acid biosynthesis TagF MNKLSIIITYFNNEDYISECIHSLKSQRNQDFDIIVVDDGSTDRSTEILQ EALKSYDKDVHFIQLQENTGHAHARNVALEQAHGQYVLFLDADDQLASYA VDYYLQHVNGLDTLIAPIHKFRSQRPQYVDKDKVRLQYASHQKSPNAILR KESACNILFKNAIIKAHQIQFNESLDIYADTSFVLEYLKYAERFVRITNF PFYYRGEVYDPFYGNTLSDQDFTNKFEDHVNSFFDAMQRTNDKRIKNFLI QRMKNEIKSGFDPALRDIKSRYVSLEDALIKIVKALKWNILKDGKVLYNL EILFLSMDDVENAKYVNDLRNKTRLVKNIVLNSKMKERSKYQLSDNEDLV DPNTIVFEAFGGKNYSDSPKYIYEYMQKHYPHLNYIWVFSKPENNNIPGN ATKVKKGSQAYYDAYAKAKYWVTNARLPLYLNKKENQMYIQTWHGTPLKR LANDMKVVRMPGTTTANYKKNFYAEASRWDRLVSPNRYSSDIFKSAFWMD EDRIWEIGYPRNDVLVNRQNDTEYIEQIKRDLNLPADKKVIMYAPTWRDD EFVKKGQYLFDLKINLANLQKEIGDEYVILLRMHYLIANALDLHGYDDFA IDVSNYNDISELYLISDALVTDYSSVMFDFGILKRPQFFFAYDIEKYDKG LRGFYMDYMNDLPGEIITDEFKLAEELKQIDQHKVKYQDKIESFYNDFCS IENGKASQYIGDYIYKDIEKKS >SH2258 tagG, teichoic acid translocation permease protein MKAWLISMSAVGSVFKEHIKNFYLVQRLAQFQIKITNTNNYLGVAWELLN PALQIMVYWFVFGMGIRSNQPIHGIPFIYWLLVGISMWFFVNQGILEGTK SVSMKFNQVAKMNFPLSIIPTYTVTSRFYGHIGLLLIIIGICIVNGIFPS IHIVQLLIYVPMTFFFTASVALFTSTLGIIVRDTQMIMQALLRILFYMSP ILWVPKDSGIGGTIGEIIKFNPVYFLAESYRAAILFHEWYFIEHWKLLLY NVIVILIFFVLGSILHRRYRDHFADFL >SH2259 tagH, teichoic acid translocation ATP-binding protein MSVSVNINNVTKEYRIYRNNKERIKDALIPKNKNNTFFALDDVSITAHEG DVIGLVGINGSGKSTLSNMIGGSISPTSGNIERNGEVSVIAINAGLNGRL TGVENIEFKMLCMGFKRKEIKQLMPQVIEFSELGEFIHQPVKNYSSGMRA KLGFSINVTINPDILVIDEALSVGDQTFTQKCLDKIYEFKEANKTIFFVS HNIRQVREFCTKIAWIEGGKLKEYGDLEEVLPKYEQFLKDFKKKSKADQK AFRKGLDEKRFIVK >SH2256 tagX, teichoic acid biosynthesis protein X MKIAIIIPVYNAEKTIRRAIKSIDTTHEVEIICVNDGSTDHSRHELTQLQ KEVKNIMIYNQDNQGAAASRNFGLAAMSDDVEAFMFLDADDQFLPGRLDK MIDYYERNQEVDIVIGQIGRGVQGDWKIIPTHEEINRESLVSLAEAPEIL QSIGPGGKLFNSKFSALRFDEDVVFCEEHTFVTRAYLTARDIQLLPLIIY GYNEQEGSITDKRADTFISYIEDARRVRQRVMEMLLLTNEKAYYSYRMDD LIVSYLIQAYLLKCSKVTPEFIDKVTHYIKDMQHTNYSGDALFRIIQAVE QGATNWTRDTYEKWRQTLIDVGIGRPGYFRFQAQVMPKKFAFSSKQLVKR TLKR